RecentMedicalFindings.com
Summarizing relevant biomedical research!
enteropathogenic escherichia coli gastrointestinal tract infection disorder     Bookmark and Share
Search webpages of this site (RecentMedicalFindings):
Didn't find what you wanted? Try it at BioMedLib™ !
Search directly on the biomedical articles using BioMedLib™ search engine:



1. Biomedical articles (top 28; 2009 to 2014)
1. |||||..... 50%  Ochoa TJ, Contreras CA: Enteropathogenic escherichia coli infection in children. Curr Opin Infect Dis; 2011 Oct;24(5):478-83
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Enteropathogenic escherichia coli infection in children.
  • PURPOSE OF REVIEW: Enteropathogenic Escherichia coli (EPEC) is an important diarrheal pathogen of young children.
  • As the diagnosis of EPEC is now based mainly on molecular criteria, there has been an important change in its prevalence.
  • The purpose of this study is to review the current epidemiology of EPEC infection and the new insights into its physiopathology.
  • However, the exact mechanisms of diarrhea in EPEC infection are not completely understood.
  • [MeSH-major] Enteropathogenic Escherichia coli. Escherichia coli Infections / epidemiology

  • MedlinePlus Health Information. consumer health - E. Coli Infections.
  • ExactAntigen/Labome. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Microbiol. 2006 Jul;44(7):2626-9 [16825399.001]
  • [Cites] Lancet. 2010 Jun 5;375(9730):1969-87 [20466419.001]
  • [Cites] FEMS Microbiol Lett. 2006 Aug;261(1):80-7 [16842363.001]
  • [Cites] J Med Microbiol. 2006 Sep;55(Pt 9):1159-63 [16914644.001]
  • [Cites] J Med Microbiol. 2006 Sep;55(Pt 9):1165-74 [16914645.001]
  • [Cites] Cell Microbiol. 2006 Oct;8(10):1669-86 [16759225.001]
  • [Cites] J Clin Microbiol. 2006 Oct;44(10):3703-11 [17021100.001]
  • [Cites] J Clin Microbiol. 2007 Mar;45(3):1038-41 [17229860.001]
  • [Cites] Infect Immun. 2007 Sep;75(9):4199-210 [17576759.001]
  • [Cites] J Clin Microbiol. 2007 Oct;45(10):3396-9 [17670930.001]
  • [Cites] Infect Immun. 2008 Jan;76(1):361-8 [17984209.001]
  • [Cites] J Appl Microbiol. 2008 Feb;104(2):403-10 [17887989.001]
  • [Cites] J Clin Microbiol. 2008 May;46(5):1752-7 [18322059.001]
  • [Cites] Trans R Soc Trop Med Hyg. 2008 Sep;102(9):852-6 [18455741.001]
  • [Cites] J Bacteriol. 2009 Jan;191(1):347-54 [18952797.001]
  • [Cites] Curr Opin Microbiol. 2009 Feb;12(1):101-9 [19144561.001]
  • [Cites] J Clin Microbiol. 2009 Jun;47(6):1915-7 [19357211.001]
  • [Cites] BMC Infect Dis. 2009;9:88 [19515227.001]
  • [Cites] Infect Immun. 2009 Aug;77(8):3501-13 [19506015.001]
  • [Cites] FEMS Microbiol Lett. 2009 Aug;297(2):137-49 [19527295.001]
  • [Cites] BMC Microbiol. 2009;9:146 [19622141.001]
  • [Cites] J Clin Microbiol. 2009 Nov;47(11):3756-9 [19759223.001]
  • [Cites] Clin Infect Dis. 2009 Dec 1;49(11):1694-702 [19857163.001]
  • [Cites] J Med Microbiol. 2010 Jan;59(Pt 1):25-31 [19797469.001]
  • [Cites] J Clin Microbiol. 2010 Jan;48(1):302-6 [19864474.001]
  • [Cites] J Infect Dev Ctries. 2009;3(11):817-42 [20061678.001]
  • [Cites] Cell Host Microbe. 2010 Jan 21;7(1):1-2 [20114020.001]
  • [Cites] Diagn Microbiol Infect Dis. 2010 Oct;68(2):117-22 [20846583.001]
  • [Cites] Cell Microbiol. 2010 Nov;12(11):1544-52 [20716205.001]
  • [Cites] Curr Opin Microbiol. 2005 Feb;8(1):28-34 [15694854.001]
  • [Cites] Infect Immun. 2005 May;73(5):2573-85 [15845459.001]
  • [Cites] Infect Immun. 2006 Feb;74(2):810-20 [16428723.001]
  • [Cites] Eur J Clin Microbiol Infect Dis. 2006 Jan;25(1):19-24 [16402227.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Feb 7;103(6):1876-81 [16446436.001]
  • [Cites] Emerg Infect Dis. 2006 Apr;12(4):597-603 [16704807.001]
  • [Cites] J Infect Dis. 2001 Mar 1;183(5):762-72 [11181153.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 2001 Jul;33(1):32-40 [11479405.001]
  • [Cites] J Clin Microbiol. 2002 Jan;40(1):294-7 [11773137.001]
  • [Cites] Int J Med Microbiol. 2002 Feb;291(6-7):469-77 [11890546.001]
  • [Cites] Emerg Infect Dis. 2002 May;8(5):508-13 [11996687.001]
  • [Cites] Microbiology. 2002 Jul;148(Pt 7):1967-78 [12101285.001]
  • [Cites] Emerg Infect Dis. 2002 Aug;8(8):855-8 [12141974.001]
  • [Cites] Mol Cell Probes. 2003 Aug;17(4):149-56 [12944116.001]
  • [Cites] J Med Microbiol. 2003 Nov;52(Pt 11):1015-9 [14532347.001]
  • [Cites] J Infect Dis. 2003 Dec 1;188(11):1685-94 [14639540.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3597-602 [14988506.001]
  • [Cites] J Med Microbiol. 2004 Nov;53(Pt 11):1137-44 [15496393.001]
  • [Cites] Infect Immun. 1991 Jan;59(1):365-71 [1702763.001]
  • [Cites] Infect Immun. 1997 Jul;65(7):2606-12 [9199427.001]
  • [Cites] J Infect Dis. 1997 Dec;176(6):1625-8 [9395379.001]
  • [Cites] Clin Microbiol Rev. 1998 Jan;11(1):142-201 [9457432.001]
  • [Cites] Microb Biotechnol. 2010 May;3(3):259-68 [21255326.001]
  • [Cites] Infect Immun. 2011 May;79(5):1833-41 [21343354.001]
  • [Cites] Rev Peru Med Exp Salud Publica. 2011 Mar;28(1):13-20 [21537764.001]
  • [Cites] Curr Opin Gastroenterol. 2011 Jan;27(1):19-23 [20838341.001]
  • [Cites] Infect Immun. 1999 Jul;67(7):3410-5 [10377120.001]
  • [Cites] J Pediatr. 2005 Jan;146(1):54-61 [15644823.001]
  • [Cites] BMC Microbiol. 2010;10:25 [20105329.001]
  • [Cites] Int Microbiol. 2006 Jun;9(2):103-10 [16835840.001]
  • (PMID = 21857511.001).
  • [ISSN] 1473-6527
  • [Journal-full-title] Current opinion in infectious diseases
  • [ISO-abbreviation] Curr. Opin. Infect. Dis.
  • [Language] eng
  • [Grant] United States / FIC NIH HHS / TW / 1K01TW007405; United States / FIC NIH HHS / TW / K01 TW007405-04
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Review
  • [Publication-country] United States
  • [Other-IDs] NLM/ NIHMS348474; NLM/ PMC3277943
  •  go-up   go-down


2. |||||..... 48%  Swennes AG, Buckley EM, Parry NM, Madden CM, García A, Morgan PB, Astrofsky KM, Fox JG: Enzootic enteropathogenic Escherichia coli infection in laboratory rabbits. J Clin Microbiol; 2012 Jul;50(7):2353-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Enzootic enteropathogenic Escherichia coli infection in laboratory rabbits.
  • Enteropathogenic Escherichia coli (EPEC) is the most important cause of persistent diarrhea in children, particularly in developing countries.
  • Animals serve as pathogenic E. coli reservoirs, and compelling evidence for cross-species EPEC transmission exists.
  • In this report, enzootic EPEC infection associated with up to 10.5% diarrhea-associated morbidity in a large laboratory Dutch Belted rabbit colony was investigated.
  • Fecal culture of 20 rabbits yielded 48 E. coli isolates, 83% of which were eae positive.
  • This report emphasizes the zoonotic potential of animal EPEC strains and the need for virulence determinant-based screening of E. coli isolates from diarrheic animals.
  • [MeSH-major] Animals, Laboratory / microbiology. Diarrhea / veterinary. Disease Outbreaks. Enteropathogenic Escherichia coli / isolation & purification. Escherichia coli Infections / veterinary. Rabbits / microbiology

  • MedlinePlus Health Information. consumer health - Diarrhea.
  • MedlinePlus Health Information. consumer health - E. Coli Infections.
  • HSDB. structure - ENROFLOXACIN.
  • ExactAntigen/Labome. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Vet Rec. 2001 Nov 3;149(18):567 [11720214.001]
  • [Cites] Infect Immun. 2012 Jan;80(1):369-80 [22025512.001]
  • [Cites] J Infect Dis. 2002 Dec 1;186(11):1682-6 [12447748.001]
  • [Cites] J Med Microbiol. 2003 Nov;52(Pt 11):1015-9 [14532347.001]
  • [Cites] Emerg Infect Dis. 2003 Dec;9(12):1592-7 [14720401.001]
  • [Cites] Gastroenterology. 2004 Aug;127(2):412-21 [15300573.001]
  • [Cites] J Med Microbiol. 2004 Nov;53(Pt 11):1137-44 [15496393.001]
  • [Cites] Emerg Infect Dis. 2004 Oct;10(10):1797-805 [15504266.001]
  • [Cites] J Infect Dis. 1977 Mar;135(3):454-62 [321703.001]
  • [Cites] N Engl J Med. 1980 Jan 10;302(2):99-101 [6985701.001]
  • [Cites] Infect Immun. 1979 Dec;26(3):1099-103 [393628.001]
  • [Cites] Infect Immun. 1983 Sep;41(3):1340-51 [6350186.001]
  • [Cites] J Clin Microbiol. 1984 Jul;20(1):34-9 [6378965.001]
  • [Cites] Ann Rech Vet. 1984;15(3):335-40 [6097152.001]
  • [Cites] J Clin Microbiol. 1989 Oct;27(10):2234-9 [2685024.001]
  • [Cites] Proc Natl Acad Sci U S A. 1990 Oct;87(20):7839-43 [2172966.001]
  • [Cites] Gut. 1991 Feb;32(2):154-8 [1864533.001]
  • [Cites] Gene. 1995 Feb 3;153(1):71-4 [7883188.001]
  • [Cites] J Clin Microbiol. 1995 May;33(5):1375-7 [7615759.001]
  • [Cites] Lab Anim Sci. 1996 Aug;46(4):381-5 [8872987.001]
  • [Cites] J Clin Microbiol. 1997 May;35(5):1103-7 [9114389.001]
  • [Cites] J Infect Dis. 1997 Jun;175(6):1382-9 [9180177.001]
  • [Cites] J Infect Dis. 1998 Apr;177(4):962-6 [9534969.001]
  • [Cites] J Clin Microbiol. 1998 Jun;36(6):1700-3 [9620403.001]
  • [Cites] Infect Immun. 1999 Jul;67(7):3410-5 [10377120.001]
  • [Cites] Vet Ophthalmol. 2005 Jul-Aug;8(4):271-5 [16008708.001]
  • [Cites] J Infect Dis. 2006 Apr 15;193(8):1125-34 [16544253.001]
  • [Cites] Emerg Infect Dis. 2006 Apr;12(4):597-603 [16704807.001]
  • [Cites] Vet Rec. 2006 Aug 5;159(6):175-8 [16891425.001]
  • [Cites] Infect Immun. 2007 Jul;75(7):3271-81 [17470543.001]
  • [Cites] Gut. 2007 Aug;56(8):1037-8 [17625138.001]
  • [Cites] J Infect Dis. 2009 Feb 15;199(4):486-93 [19125676.001]
  • [Cites] Lett Appl Microbiol. 2009 Jul;49(1):53-9 [19413771.001]
  • [Cites] BMC Infect Dis. 2009;9:88 [19515227.001]
  • [Cites] Appl Environ Microbiol. 2009 Dec;75(23):7399-408 [19801470.001]
  • [Cites] J Infect Dis. 2000 Mar;181(3):1027-33 [10720527.001]
  • [Cites] Microbes Infect. 2000 Jan;2(1):5-16 [10717535.001]
  • [Cites] N Engl J Med. 2000 Jun 29;342(26):1930-6 [10874060.001]
  • [Cites] Emerg Infect Dis. 2000 Sep-Oct;6(5):458-65 [10998375.001]
  • [Cites] J Infect Dis. 2001 Jul 15;184(2):227-30 [11424022.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 2001 Jul;33(1):32-40 [11479405.001]
  • [Cites] J Infect Dis. 2001 Sep 15;184(6):803-7 [11517446.001]
  • [Cites] Antimicrob Agents Chemother. 2010 Sep;54(9):3790-8 [20585113.001]
  • [Cites] ILAR J. 2010;51(3):221-32 [21131723.001]
  • [Cites] N Engl J Med. 2011 Aug 25;365(8):709-17 [21793740.001]
  • [Cites] Curr Opin Infect Dis. 2011 Oct;24(5):478-83 [21857511.001]
  • [Cites] Curr Opin Infect Dis. 2001 Oct;14(5):567-71 [11964877.001]
  • (PMID = 22573597.001).
  • [ISSN] 1098-660X
  • [Journal-full-title] Journal of clinical microbiology
  • [ISO-abbreviation] J. Clin. Microbiol.
  • [Language] eng
  • [Databank-accession-numbers] GENBANK/ JQ700206
  • [Grant] United States / NCRR NIH HHS / RR / T32 RR070036
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anti-Bacterial Agents; 0 / DNA, Bacterial; 0 / Fluoroquinolones; 93106-60-6 / enrofloxacin
  • [Other-IDs] NLM/ PMC3405579
  •  go-up   go-down


3. ||||...... 44%  Schüller S, Lucas M, Kaper JB, Girón JA, Phillips AD: The ex vivo response of human intestinal mucosa to enteropathogenic Escherichia coli infection. Cell Microbiol; 2009 Mar;11(3):521-30
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The ex vivo response of human intestinal mucosa to enteropathogenic Escherichia coli infection.
  • In vitro organ culture (IVOC) represents a gold standard model to study enteropathogenic E. coli (EPEC) infection of human intestinal mucosa.
  • A polarized IVOC system (pIVOC) was developed in order to overcome such limitations: apical EPEC infection produced negligible bacterial leakage via biopsy edges, resulted in enhanced colonization compared with standard IVOC, and showed evidence of bacterial detachment, as in natural rabbit EPEC infections.
  • Examination of mucosal innate immune responses in pIVOC showed both interleukin (IL)-8 mRNA and protein levels were significantly increased after apical EPEC infection.
  • Immunofluorescence staining of EPEC-infected small intestinal biopsies revealed apical and basolateral distribution of Toll-like receptor (TLR) 5 on epithelium, suggesting that EPEC can trigger mucosal IL-8 responses by apical flagellin/TLR5 interaction ex vivo and does not require access to the basolateral membrane as postulated in cell culture models.
  • [MeSH-major] Enteropathogenic Escherichia coli / growth & development. Intestinal Mucosa / microbiology
  • [MeSH-minor] Escherichia coli Proteins / genetics. Escherichia coli Proteins / immunology. Gene Deletion. Gene Expression Profiling. Humans. Interleukin-8 / biosynthesis. Organ Culture Techniques / methods. Toll-Like Receptor 5 / biosynthesis

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6640-5 [10829079.001]
  • [Cites] Proc Natl Acad Sci U S A. 1990 Oct;87(20):7839-43 [2172966.001]
  • [Cites] Nature. 2001 Apr 26;410(6832):1099-103 [11323673.001]
  • [Cites] Infect Immun. 2001 Jul;69(7):4580-9 [11402002.001]
  • [Cites] J Immunol. 2001 Aug 15;167(4):1882-5 [11489966.001]
  • [Cites] FEMS Microbiol Rev. 2005 Jan;29(1):83-98 [15652977.001]
  • [Cites] Infect Immun. 2005 Jun;73(6):3367-74 [15908363.001]
  • [Cites] Am J Physiol. 1995 Feb;268(2 Pt 1):G374-9 [7864134.001]
  • [Cites] Am J Physiol. 1996 Apr;270(4 Pt 1):G634-45 [8928793.001]
  • [Cites] Infect Immun. 1996 Nov;64(11):4480-7 [8890195.001]
  • [Cites] Infect Immun. 1996 Nov;64(11):4751-60 [8890236.001]
  • [Cites] Clin Microbiol Rev. 1998 Jan;11(1):142-201 [9457432.001]
  • [Cites] Mol Microbiol. 1999 Feb;31(4):1229-41 [10096089.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Sep 20;102(38):13610-5 [16157881.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2006 Apr;290(4):G685-94 [16322091.001]
  • [Cites] Cell Microbiol. 2006 May;8(5):869-79 [16611235.001]
  • [Cites] Cell Microbiol. 2007 May;9(5):1352-64 [17474908.001]
  • [Cites] Cell Microbiol. 2007 Aug;9(8):1909-21 [17388785.001]
  • [Cites] J Bacteriol. 2007 Oct;189(20):7426-35 [17693516.001]
  • [Cites] Infect Immun. 2008 Jan;76(1):361-8 [17984209.001]
  • [Cites] Infect Immun. 2008 Apr;76(4):1410-22 [18227166.001]
  • [Cites] Nat Cell Biol. 2001 Sep;3(9):856-9 [11533668.001]
  • [Cites] Mol Microbiol. 2002 Apr;44(2):361-79 [11972776.001]
  • [Cites] Cell Microbiol. 2002 Oct;4(10):635-48 [12366401.001]
  • [Cites] Gastroenterology. 2002 Nov;123(5):1607-15 [12404235.001]
  • [Cites] Infect Immun. 2003 Apr;71(4):2120-9 [12654834.001]
  • [Cites] J Immunol. 2003 May 15;170(10):5165-75 [12734364.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2003 Aug;285(2):G282-90 [12702497.001]
  • [Cites] Cell Microbiol. 2004 Mar;6(3):243-54 [14764108.001]
  • [Cites] Cell Microbiol. 2004 Mar;6(3):289-301 [14764112.001]
  • [Cites] Microbiology. 2004 Mar;150(Pt 3):527-38 [14993302.001]
  • [Cites] J Immunol. 2004 Apr 15;172(8):5056-62 [15067088.001]
  • [Cites] J Clin Invest. 2004 May;113(9):1296-306 [15124021.001]
  • [Cites] Clin Exp Immunol. 2004 Jun;136(3):521-6 [15147355.001]
  • [Cites] J Biol Chem. 2004 Oct 8;279(41):42984-92 [15302888.001]
  • [Cites] N Engl J Med. 1980 Jan 10;302(2):99-101 [6985701.001]
  • [Cites] Infect Immun. 1983 Sep;41(3):1340-51 [6350186.001]
  • [Cites] Ultrastruct Pathol. 1983 Jun;4(4):291-304 [6359611.001]
  • [Cites] J Infect Dis. 1985 Sep;152(3):550-9 [2863318.001]
  • [Cites] Infect Immun. 1987 Jan;55(1):69-77 [3539808.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 1987 May-Jun;6(3):430-8 [3430250.001]
  • [Cites] Infect Immun. 1989 Apr;57(4):1290-8 [2647635.001]
  • [Cites] Infect Immun. 2000 Dec;68(12):7010-7 [11083826.001]
  • (PMID = 19134113.001).
  • [ISSN] 1462-5822
  • [Journal-full-title] Cellular microbiology
  • [ISO-abbreviation] Cell. Microbiol.
  • [Language] eng
  • [Grant] United States / NIDDK NIH HHS / DK / R01 DK058957-07; United States / NIDDK NIH HHS / DK / R01 DK058957-09; United States / NIDDK NIH HHS / DK / R01DK58957; United States / NIAID NIH HHS / AI / R37 AI021657-22; United States / NIAID NIH HHS / AI / R37 AI021657-23; United States / NIAID NIH HHS / AI / R37AI21657
  • [Publication-type] In Vitro; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Escherichia coli Proteins; 0 / FliC protein, E coli; 0 / Interleukin-8; 0 / TLR5 protein, human; 0 / Toll-Like Receptor 5
  • [Other-IDs] NLM/ NIHMS105491; NLM/ PMC2676445
  •  go-up   go-down


Advertisement

4. ||||...... 44%  Gouveia EM, Silva IS, Nakazato G, Araujo FR, Chang MR: Experimental infection with enteropathogenic Escherichia coli identified by PCR using enteric-coated capsules in boxer pups. Acta Cir Bras; 2011 Apr;26(2):144-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Experimental infection with enteropathogenic Escherichia coli identified by PCR using enteric-coated capsules in boxer pups.
  • PURPOSE: To verify the possibility of an experimental infection with enteropathogenic Escherichia coli and to confirm by PCR that the symptoms manifested after infection were due to the virulence factors of the studied bacteria.
  • Gelatinous capsules coated with enteric-coating solution were used for the inoculation of strains. E. coli isolation from feces was performed for all tested animals, and the extracted DNA was subjected to Polymerase Chain Reaction (PCR).
  • CONCLUSION: The efficiency of PCR for the studied strains indicates that this technique can be recommended for the diagnosis of enteropathogenic Escherichia coli as a differential from other pathogens causing diarrhea.
  • It may also be used in the future to verify whether other virulence factors (bfpA gene and EAF plasmid) persist after infection and to assess the pathogenicity of these bacteria.
  • [MeSH-major] Enteropathogenic Escherichia coli / genetics. Escherichia coli Infections / microbiology. Polymerase Chain Reaction

  • MedlinePlus Health Information. consumer health - E. Coli Infections.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21445479.001).
  • [ISSN] 1678-2674
  • [Journal-full-title] Acta cirúrgica brasileira / Sociedade Brasileira para Desenvolvimento Pesquisa em Cirurgia
  • [ISO-abbreviation] Acta Cir Bras
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Brazil
  • [Chemical-registry-number] 0 / DNA, Bacterial; 0 / Virulence Factors
  •  go-up   go-down


5. ||||...... 43%  Hemrajani C, Berger CN, Robinson KS, Marchès O, Mousnier A, Frankel G: NleH effectors interact with Bax inhibitor-1 to block apoptosis during enteropathogenic Escherichia coli infection. Proc Natl Acad Sci U S A; 2010 Feb 16;107(7):3129-34
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] NleH effectors interact with Bax inhibitor-1 to block apoptosis during enteropathogenic Escherichia coli infection.
  • The human pathogens enteropathogenic (EPEC) and enterohemorrhagic Escherichia coli and the related mouse pathogen Citrobacter rodentium subvert a variety of host cell signaling pathways via their plethora of type III secreted effectors, including triggering of an early apoptotic response.
  • During EPEC infection, NleH effectors inhibit elevation of cytosolic Ca(2+) concentrations, nuclear condensation, caspase-3 activation, and membrane blebbing and promote cell survival.
  • [MeSH-major] Apoptosis / drug effects. Enterobacteriaceae Infections / metabolism. Escherichia coli Proteins / metabolism. Membrane Proteins / metabolism. Virulence Factors / metabolism
  • [MeSH-minor] Animals. Blotting, Western. Calcium / metabolism. Caspase 3 / metabolism. Cell Nucleus / drug effects. Citrobacter rodentium. Cloning, Molecular. Cytosol / metabolism. Escherichia coli. Female. Mice. Microscopy, Electron, Scanning. Microscopy, Fluorescence. Specific Pathogen-Free Organisms. Two-Hybrid System Techniques

  • HSDB. structure - CALCIUM, ELEMENTAL.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Invest. 2001 Mar;107(5):621-9 [11238563.001]
  • [Cites] J Bacteriol. 2009 Jan;191(1):347-54 [18952797.001]
  • [Cites] Curr Opin Cell Biol. 2001 Jun;13(3):349-55 [11343907.001]
  • [Cites] Infect Immun. 2001 Dec;69(12):7356-64 [11705908.001]
  • [Cites] Nat Rev Cancer. 2002 Sep;2(9):647-56 [12209154.001]
  • [Cites] Cell Microbiol. 2003 Feb;5(2):99-109 [12580946.001]
  • [Cites] Nat Rev Mol Cell Biol. 2003 Jul;4(7):552-65 [12838338.001]
  • [Cites] Gene. 2003 Dec 24;323:101-13 [14659883.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3597-602 [14988506.001]
  • [Cites] Mol Cell. 2004 Aug 13;15(3):355-66 [15304216.001]
  • [Cites] Cell Microbiol. 2004 Nov;6(11):1097-111 [15469437.001]
  • [Cites] Infect Immun. 2004 Nov;72(11):6408-17 [15501771.001]
  • [Cites] Infect Immun. 1987 Jan;55(1):69-77 [3539808.001]
  • [Cites] J Pharmacol Toxicol Methods. 1997 Jun;37(4):215-28 [9279777.001]
  • [Cites] Biochem J. 1997 Aug 15;326 ( Pt 1):1-16 [9337844.001]
  • [Cites] Cell. 1997 Nov 14;91(4):479-89 [9390557.001]
  • [Cites] Clin Microbiol Rev. 1998 Jan;11(1):142-201 [9457432.001]
  • [Cites] Int J Med Microbiol. 2009 Feb;299(2):121-32 [18771950.001]
  • [Cites] Cell Host Microbe. 2009 Jun 18;5(6):514-6 [19527878.001]
  • [Cites] Anticancer Res. 2009 Aug;29(8):2893-8 [19661292.001]
  • [Cites] Gastroenterology. 2009 Apr;136(4):1297-1307, e1-3 [19250983.001]
  • [Cites] Mol Cell. 1998 Feb;1(3):337-46 [9660918.001]
  • [Cites] Mol Microbiol. 1998 Dec;30(5):911-21 [9988469.001]
  • [Cites] Infect Immun. 1999 May;67(5):2575-84 [10225923.001]
  • [Cites] J Biol Chem. 2005 Mar 11;280(10):9058-64 [15642738.001]
  • [Cites] Infect Immun. 2005 May;73(5):2573-85 [15845459.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):14046-51 [16162672.001]
  • [Cites] Cell Microbiol. 2005 Dec;7(12):1697-706 [16309456.001]
  • [Cites] Cell Microbiol. 2006 Apr;8(4):677-89 [16548893.001]
  • [Cites] Inflamm Bowel Dis. 2006 May;12(5):413-24 [16670531.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Oct 3;103(40):14941-6 [16990433.001]
  • [Cites] J Biol Chem. 2006 Oct 20;281(42):31495-501 [16940052.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Dec 5;103(49):18745-50 [17124169.001]
  • [Cites] Cell Microbiol. 2007 Mar;9(3):680-93 [17064289.001]
  • [Cites] Infect Immun. 2007 May;75(5):2316-24 [17339360.001]
  • [Cites] Toxicol Pathol. 2007 Jun;35(4):495-516 [17562483.001]
  • [Cites] Infect Immun. 2008 Nov;76(11):4804-13 [18725419.001]
  • [Cites] Oncogene. 2008 Oct 27;27(50):6407-18 [18955969.001]
  • [Cites] Cell Microbiol. 2001 Apr;3(4):197-211 [11298644.001]
  • (PMID = 20133763.001).
  • [ISSN] 1091-6490
  • [Journal-full-title] Proceedings of the National Academy of Sciences of the United States of America
  • [ISO-abbreviation] Proc. Natl. Acad. Sci. U.S.A.
  • [Language] eng
  • [Grant] United Kingdom / Medical Research Council / / ; United Kingdom / Wellcome Trust / /
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Escherichia coli Proteins; 0 / Membrane Proteins; 0 / Tmbim6 protein, mouse; 0 / Virulence Factors; EC 3.4.22.- / Caspase 3; SY7Q814VUP / Calcium
  • [Other-IDs] NLM/ PMC2840288
  •  go-up   go-down


6. ||||...... 41%  Gareau MG, Ho NK, Brenner D, Sousa AJ, Lebourhis L, Mak TW, Girardin SE, Philpott DJ, Sherman PM: Enterohaemorrhagic, but not enteropathogenic, Escherichia coli infection of epithelial cells disrupts signalling responses to tumour necrosis factor-alpha. Microbiology; 2011 Oct;157(Pt 10):2963-73
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Enterohaemorrhagic, but not enteropathogenic, Escherichia coli infection of epithelial cells disrupts signalling responses to tumour necrosis factor-alpha.
  • Enterohaemorrhagic Escherichia coli (EHEC), serotype O157 : H7 is a non-invasive, pathogenic bacterium that employs a type III secretion system (T3SS) to inject effector proteins into infected cells.
  • Using complementary techniques, stimulation with TNFα caused activation of NF-κB, as determined by luciferase reporter assay (increase in gene expression), Western blotting (phosphorylation of IκBα), immunofluorescence (p65 nuclear translocation) and immunoassay (CXCL-8 secretion), and each was blocked by EHEC O157 : H7 infection.
  • In contrast, subversion of host cell signalling was not observed following exposure to either enteropathogenic E. coli, strain E2348/69 (O127 : H6) or the laboratory E. coli strain HB101.
  • [MeSH-major] Cell Line / microbiology. Enterohemorrhagic Escherichia coli / physiology. Epithelial Cells / metabolism. Escherichia coli Infections / metabolism. Escherichia coli O157 / physiology. Signal Transduction. Tumor Necrosis Factor-alpha / metabolism

  • MedlinePlus Health Information. consumer health - E. Coli Infections.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21798984.001).
  • [ISSN] 1465-2080
  • [Journal-full-title] Microbiology (Reading, England)
  • [ISO-abbreviation] Microbiology (Reading, Engl.)
  • [Language] eng
  • [Grant] Canada / Canadian Institutes of Health Research / / MOP-89894
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / NF-kappa B; 0 / Tumor Necrosis Factor-alpha
  •  go-up   go-down


7. |||....... 33%  Calderon Toledo C, Arvidsson I, Karpman D: Cross-reactive protection against enterohemorrhagic Escherichia coli infection by enteropathogenic E. coli in a mouse model. Infect Immun; 2011 Jun;79(6):2224-33
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cross-reactive protection against enterohemorrhagic Escherichia coli infection by enteropathogenic E. coli in a mouse model.
  • Enteropathogenic Escherichia coli (EPEC) and enterohemorrhagic E. coli (EHEC) are related attaching and effacing (A/E) pathogens.
  • We used a mouse model to inoculate BALB/c mice intragastrically, first with EPEC and then with EHEC (E. coli O157:H7).
  • Four control groups received either a nonpathogenic E. coli (NPEC) strain followed by EHEC (NPEC/EHEC), phosphate-buffered saline (PBS) followed by EHEC (PBS/EHEC), EPEC/PBS, or PBS/PBS.
  • EPEC colonized the intestine after challenge, and mice developed serum antibodies to intimin and E. coli secreted protein B (encoded in the LEE).
  • Prechallenge with an EPEC strain had a protective effect after EHEC infection, as only a few mice developed mild symptoms, from which they recovered.
  • These mice had an increase in body weight similar to that in control animals, and tissue morphology exhibited mild intestinal changes and normal renal histology.
  • All mice that were not prechallenged with the EPEC strain developed mild to severe symptoms after EHEC infection, with weight loss as well as intestinal and renal histopathological changes.
  • These data suggest that EPEC may protect against EHEC infection in this mouse model.
  • [MeSH-major] Antibodies, Bacterial / immunology. Cross Protection / immunology. Enterohemorrhagic Escherichia coli / immunology. Enteropathogenic Escherichia coli / immunology. Escherichia coli Infections / immunology

  • MedlinePlus Health Information. consumer health - E. Coli Infections.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Infect Immun. 2000 Jan;68(1):64-71 [10603369.001]
  • [Cites] J Infect Dis. 1998 Jun;177(6):1750-3 [9607864.001]
  • [Cites] J Clin Microbiol. 2000 Jul;38(7):2696-700 [10878066.001]
  • [Cites] Nature. 2000 Jul 6;406(6791):64-7 [10894541.001]
  • [Cites] Gut. 2000 Sep;47(3):377-81 [10940275.001]
  • [Cites] Cell Microbiol. 2001 Oct;3(10):669-79 [11580752.001]
  • [Cites] Gut. 2002 Feb;50(2):180-5 [11788556.001]
  • [Cites] J Clin Microbiol. 2002 Apr;40(4):1436-40 [11923369.001]
  • [Cites] Infect Immun. 2002 May;70(5):2414-8 [11953378.001]
  • [Cites] Pediatr Nephrol. 2002 Mar;17(3):201-11 [11956862.001]
  • [Cites] Curr Opin Infect Dis. 2001 Jun;14(3):295-300 [11964846.001]
  • [Cites] Emerg Infect Dis. 2002 May;8(5):508-13 [11996687.001]
  • [Cites] Nat Rev Immunol. 2003 Feb;3(2):169-76 [12563300.001]
  • [Cites] Pediatr Allergy Immunol. 2003 Jun;14(3):222-8 [12787303.001]
  • [Cites] Infect Immun. 2004 Jan;72(1):168-75 [14688094.001]
  • [Cites] Eur J Clin Microbiol Infect Dis. 2004 Mar;23(3):208-11 [14986162.001]
  • [Cites] Infect Immun. 1998 Aug;66(8):3810-7 [9673266.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 1998 Aug;27(2):166-71 [9702647.001]
  • [Cites] J Med Microbiol. 1998 Sep;47(9):781-90 [9736160.001]
  • [Cites] J Infect Dis. 1999 Jan;179(1):269-74 [9841853.001]
  • [Cites] Eur J Pediatr. 2005 Jan;164(1):37-43 [15549380.001]
  • [Cites] J Bacteriol. 2005 Mar;187(5):1783-91 [15716450.001]
  • [Cites] Infect Immun. 2005 Oct;73(10):6608-19 [16177337.001]
  • [Cites] FEMS Microbiol Lett. 2006 Feb;255(2):187-202 [16448495.001]
  • [Cites] Infect Immun. 2006 Mar;74(3):1962-6 [16495575.001]
  • [Cites] Microbiology. 2007 Mar;153(Pt 3):794-802 [17322200.001]
  • [Cites] Am J Pathol. 2008 Nov;173(5):1428-39 [18832584.001]
  • [Cites] Trends Immunol. 2009 Oct;30(10):475-87 [19781994.001]
  • [Cites] J Infect Dis. 1989 Feb;159(2):344-7 [2644374.001]
  • [Cites] Infect Immun. 1990 Aug;58(8):2438-45 [2196227.001]
  • [Cites] J Infect Dis. 1991 Jun;163(6):1247-55 [1903799.001]
  • [Cites] J Infect Dis. 1991 Aug;164(2):331-7 [1856482.001]
  • [Cites] Infect Immun. 1991 Dec;59(12):4302-9 [1682258.001]
  • [Cites] Science. 1991 Nov 1;254(5032):710-3 [1683004.001]
  • [Cites] J Clin Microbiol. 1993 May;31(5):1200-5 [8501218.001]
  • [Cites] Int Arch Allergy Immunol. 1994;103(3):307-10 [8111250.001]
  • [Cites] J Clin Microbiol. 1995 May;33(5):1375-7 [7615759.001]
  • [Cites] Infect Immun. 1995 Sep;63(9):3621-7 [7642299.001]
  • [Cites] Infect Immun. 1996 Nov;64(11):4826-9 [8890245.001]
  • [Cites] J Infect Dis. 1985 May;151(5):775-82 [3886804.001]
  • [Cites] J Infect Dis. 1985 Sep;152(3):550-9 [2863318.001]
  • [Cites] J Infect Dis. 1997 Mar;175(3):611-20 [9041333.001]
  • [Cites] Cell. 1997 Nov 14;91(4):511-20 [9390560.001]
  • [Cites] Infect Immun. 1998 Jan;66(1):52-8 [9423838.001]
  • [Cites] Clin Microbiol Rev. 1998 Jan;11(1):142-201 [9457432.001]
  • [Cites] EMBO J. 1998 Apr 15;17(8):2166-76 [9545230.001]
  • [Cites] Mol Microbiol. 1998 Apr;28(1):1-4 [9593291.001]
  • [Cites] Infect Immun. 2000 Jun;68(6):3689-95 [10816529.001]
  • (PMID = 21402761.001).
  • [ISSN] 1098-5522
  • [Journal-full-title] Infection and immunity
  • [ISO-abbreviation] Infect. Immun.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antibodies, Bacterial
  • [Other-IDs] NLM/ PMC3125830
  •  go-up   go-down


8. |||....... 29%  Kobayashi T, Ogawa M, Sanada T, Mimuro H, Kim M, Ashida H, Akakura R, Yoshida M, Kawalec M, Reichhart JM, Mizushima T, Sasakawa C: The Shigella OspC3 effector inhibits caspase-4, antagonizes inflammatory cell death, and promotes epithelial infection. Cell Host Microbe; 2013 May 15;13(5):570-83
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The Shigella OspC3 effector inhibits caspase-4, antagonizes inflammatory cell death, and promotes epithelial infection.
  • Caspase-mediated inflammatory cell death acts as an intrinsic defense mechanism against infection.
  • In a screen for Shigella flexneri effectors that regulate cell death during infection, we discovered that Shigella infection induced acute inflammatory, caspase-4-dependent epithelial cell death, which is counteracted by the bacterial OspC3 effector.
  • Infection of guinea pigs with a Shigella ospC3-deficient mutant resulted in enhanced inflammatory cell death and associated symptoms, correlating with decreased bacterial burdens.
  • Salmonella Typhimurium and enteropathogenic Escherichia coli infection also induced caspase-4-dependent epithelial death.
  • These findings highlight the importance of caspase-4-dependent innate immune responses and demonstrate that Shigella delivers a caspase-4-specific inhibitor to delay epithelial cell death and promote infection.
  • [MeSH-minor] Animals. Cell Line. DNA, Bacterial / chemistry. DNA, Bacterial / genetics. Disease Models, Animal. Dysentery, Bacillary / immunology. Dysentery, Bacillary / microbiology. Dysentery, Bacillary / pathology. Escherichia coli / immunology. Escherichia coli / pathogenicity. Gene Knockout Techniques. Guinea Pigs. Humans. Molecular Sequence Data. Protein Binding. Protein Interaction Mapping. Salmonella typhimurium / immunology. Salmonella typhimurium / pathogenicity. Sequence Analysis, DNA. Virulence Factors / genetics. Virulence Factors / metabolism

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2013 Elsevier Inc. All rights reserved.
  • (PMID = 23684308.001).
  • [ISSN] 1934-6069
  • [Journal-full-title] Cell host & microbe
  • [ISO-abbreviation] Cell Host Microbe
  • [Language] eng
  • [Databank-accession-numbers] GENBANK/ AB819724/ AB819725/ AB819726
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Bacterial Proteins; 0 / DNA, Bacterial; 0 / Enzyme Inhibitors; 0 / Virulence Factors; EC 3.4.22.- / CASP4 protein, human; EC 3.4.22.- / Caspases, Initiator
  •  go-up   go-down


9. |||....... 28%  Bardiau M, Szalo M, Mainil JG: Initial adherence of EPEC, EHEC and VTEC to host cells. Vet Res; 2010 Sep-Oct;41(5):57
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Initial adherence to host cells is the first step of the infection of enteropathogenic Escherichia coli (EPEC), enterohaemorrhagic Escherichia coli (EHEC) and verotoxigenic Escherichia coli (VTEC) strains.
  • The importance of this step in the infection resides in the fact that (1) adherence is the first contact between bacteria and intestinal cells without which the other steps cannot occur and (2) adherence is the basis of host specificity for a lot of pathogens.
  • [MeSH-major] Bacterial Adhesion / physiology. Enterohemorrhagic Escherichia coli / physiology. Enteropathogenic Escherichia coli / physiology. Intestines / cytology. Shiga-Toxigenic Escherichia coli / physiology

  • COS Scholar Universe. author profiles.
  • ExactAntigen/Labome. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © INRA, EDP Sciences, 2010.
  • [Cites] DNA Res. 2001 Feb 28;8(1):11-22 [11258796.001]
  • [Cites] Infect Immun. 2001 Jul;69(7):4447-57 [11401985.001]
  • [Cites] Infect Immun. 2001 Nov;69(11):6660-9 [11598035.001]
  • [Cites] Infect Immun. 2001 Nov;69(11):6999-7009 [11598075.001]
  • [Cites] Infect Immun. 2001 Dec;69(12):7941-5 [11705982.001]
  • [Cites] Cell Microbiol. 2002 Jan;4(1):29-42 [11856171.001]
  • [Cites] Vet Microbiol. 2002 May 24;86(4):303-11 [11955780.001]
  • [Cites] Emerg Infect Dis. 2002 May;8(5):508-13 [11996687.001]
  • [Cites] Mol Microbiol. 2002 Aug;45(4):951-66 [12180916.001]
  • [Cites] Infect Immun. 2002 Sep;70(9):5158-66 [12183566.001]
  • [Cites] Vet Microbiol. 2002 Oct 2;89(1):41-51 [12223161.001]
  • [Cites] Infect Immun. 2002 Oct;70(10):5416-27 [12228266.001]
  • [Cites] Vet Res. 2005 May-Jun;36(3):289-311 [15845227.001]
  • [Cites] J Appl Microbiol. 2005;98(6):1332-44 [15916647.001]
  • [Cites] Appl Environ Microbiol. 2005 Jul;71(7):3405-12 [16000742.001]
  • [Cites] J Clin Microbiol. 2005 Aug;43(8):4052-6 [16081950.001]
  • [Cites] Vet Microbiol. 2005 Sep 30;110(1-2):35-9 [16026940.001]
  • [Cites] Vet Microbiol. 2005 Sep 30;110(1-2):77-85 [16125342.001]
  • [Cites] Anim Health Res Rev. 2005 Jun;6(1):17-39 [16164007.001]
  • [Cites] J Infect Dis. 2005 Oct 15;192(8):1422-9 [16170761.001]
  • [Cites] Vet Microbiol. 2005 Oct 31;110(3-4):277-83 [16169688.001]
  • [Cites] Infect Immun. 2006 Jan;74(1):265-72 [16368980.001]
  • [Cites] Res Microbiol. 2006 Mar;157(2):153-61 [16125910.001]
  • [Cites] FEMS Microbiol Lett. 2007 Sep;274(2):329-34 [17651390.001]
  • [Cites] Infect Immun. 1977 Dec;18(3):775-9 [338490.001]
  • [Cites] Gastroenterology. 1983 Oct;85(4):837-45 [6136449.001]
  • [Cites] Infect Immun. 1983 Sep;41(3):1340-51 [6350186.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 1983;2(3):534-8 [6352891.001]
  • [Cites] J Clin Microbiol. 1983 Sep;18(3):512-20 [6355145.001]
  • [Cites] J Infect Dis. 1985 Sep;152(3):550-9 [2863318.001]
  • [Cites] Infect Immun. 1986 Aug;53(2):339-46 [3525410.001]
  • [Cites] Rev Infect Dis. 1987 Jan-Feb;9(1):28-53 [3547577.001]
  • [Cites] Adv Exp Med Biol. 1988;228:465-94 [2459930.001]
  • [Cites] Infect Immun. 1989 May;57(5):1506-11 [2565291.001]
  • [Cites] J Clin Microbiol. 1989 Jun;27(6):1307-11 [2568996.001]
  • [Cites] J Clin Microbiol. 1990 Apr;28(4):651-3 [1970575.001]
  • [Cites] Vet Microbiol. 1990 Nov;25(2-3):267-81 [1980757.001]
  • [Cites] Res Microbiol. 2006 Apr;157(3):263-6 [16171978.001]
  • [Cites] Infect Immun. 2006 Apr;74(4):2233-44 [16552054.001]
  • [Cites] Environ Microbiol. 2006 Jun;8(6):1033-47 [16689724.001]
  • [Cites] J Bacteriol. 2006 Jun;188(11):3952-61 [16707687.001]
  • [Cites] Infect Immun. 2006 Jun;74(6):3427-36 [16714573.001]
  • [Cites] Microbiology. 2006 Aug;152(Pt 8):2405-20 [16849804.001]
  • [Cites] Microbes Infect. 2006 Jul;8(8):2021-6 [16797203.001]
  • [Cites] Infect Immun. 2006 Oct;74(10):5747-55 [16988252.001]
  • [Cites] Vet Microbiol. 2006 Oct 31;117(2-4):328-32 [16872761.001]
  • [Cites] Microb Pathog. 2006 Dec;41(6):207-17 [16954050.001]
  • [Cites] Res Microbiol. 2007 Jan-Feb;158(1):97-104 [17125971.001]
  • [Cites] Vet Microbiol. 2007 Mar 10;120(3-4):308-19 [17140750.001]
  • [Cites] Vet Microbiol. 2007 Jun 21;122(3-4):332-41 [17353102.001]
  • [Cites] Mol Microbiol. 2000 Jan;35(2):275-88 [10652089.001]
  • [Cites] Adv Exp Med Biol. 1999;473:179-84 [10659356.001]
  • [Cites] Infect Immun. 2000 Mar;68(3):1400-7 [10678953.001]
  • [Cites] Vet Microbiol. 2000 Feb;71(3-4):255-67 [10703708.001]
  • [Cites] Vet Clin North Am Food Anim Pract. 2000 Mar;16(1):175-85 [10707419.001]
  • [Cites] Infect Immun. 2000 Apr;68(4):2148-55 [10722613.001]
  • [Cites] Infect Immun. 2000 May;68(5):3040-7 [10769012.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):8799-806 [10922038.001]
  • [Cites] Vet Q. 2000 Jul;22(3):162-6 [10952448.001]
  • [Cites] Infect Immun. 2000 Nov;68(11):6472-7 [11035762.001]
  • [Cites] Clin Diagn Lab Immunol. 2001 Jan;8(1):143-9 [11139209.001]
  • [Cites] Res Microbiol. 2000 Dec;151(10):865-71 [11191812.001]
  • [Cites] Nature. 2001 Jan 25;409(6819):529-33 [11206551.001]
  • [Cites] Infect Immun. 2001 Feb;69(2):640-9 [11159950.001]
  • [Cites] Methods Mol Med. 2003;73:75-89 [12375444.001]
  • [Cites] Infect Immun. 2002 Dec;70(12):6761-9 [12438351.001]
  • [Cites] Kansenshogaku Zasshi. 2002 Nov;76(11):911-20 [12508474.001]
  • [Cites] Res Microbiol. 2002 Dec;153(10):653-8 [12558184.001]
  • [Cites] Vet Microbiol. 2003 May 2;93(1):39-51 [12591205.001]
  • [Cites] J Clin Microbiol. 2003 Apr;41(4):1775-8 [12682185.001]
  • [Cites] Microbiology. 2003 Jul;149(Pt 7):1871-82 [12855738.001]
  • [Cites] Infect Immun. 2003 Aug;71(8):4516-25 [12874331.001]
  • [Cites] J Clin Microbiol. 2003 Nov;41(11):4930-40 [14605120.001]
  • [Cites] Infect Immun. 2004 Sep;72(9):5402-11 [15322038.001]
  • [Cites] FEMS Microbiol Lett. 2004 Sep 15;238(2):333-44 [15358418.001]
  • [Cites] J Clin Microbiol. 2004 Oct;42(10):4697-701 [15472329.001]
  • [Cites] Science. 1991 Nov 1;254(5032):710-3 [1683004.001]
  • [Cites] J Cell Biol. 1991 Nov;115(4):1021-9 [1683351.001]
  • [Cites] Infect Immun. 1992 Jan;60(1):13-8 [1729177.001]
  • [Cites] Infect Immun. 1992 May;60(5):1963-71 [1348723.001]
  • [Cites] Mol Microbiol. 1992 Jun;6(11):1539-46 [1625582.001]
  • [Cites] Infect Immun. 1992 Oct;60(10):3953-61 [1398907.001]
  • [Cites] Vet Microbiol. 1992 Sep;32(2):163-75 [1359692.001]
  • [Cites] Mol Microbiol. 1992 Nov;6(22):3427-37 [1362446.001]
  • [Cites] Epidemiol Infect. 1993 Feb;110(1):9-16 [8432328.001]
  • [Cites] Mol Microbiol. 1993 Feb;7(4):563-75 [8096320.001]
  • [Cites] Zentralbl Bakteriol. 1993 Apr;278(2-3):197-208 [8347926.001]
  • [Cites] Vet Microbiol. 1993 May;35(1-2):79-89 [8395746.001]
  • [Cites] Vet Microbiol. 1995 Aug;45(4):281-95 [7483242.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):279-83 [8552622.001]
  • [Cites] J Bacteriol. 1996 May;178(9):2613-28 [8626330.001]
  • [Cites] Mol Microbiol. 1996 Apr;20(2):325-37 [8733231.001]
  • [Cites] Vet Microbiol. 1996 May;50(1-2):105-15 [8810012.001]
  • [Cites] Mol Microbiol. 1996 Apr;20(1):87-100 [8861207.001]
  • [Cites] Microb Pathog. 1996 Sep;21(3):183-92 [8878015.001]
  • [Cites] J Clin Microbiol. 1996 Dec;34(12):3101-7 [8940455.001]
  • [Cites] Infect Immun. 1997 Feb;65(2):847-51 [9009356.001]
  • [Cites] FEMS Immunol Med Microbiol. 1997 Jul;18(3):153-61 [9271166.001]
  • [Cites] J Vet Med Sci. 1997 Oct;59(10):917-21 [9362041.001]
  • [Cites] Infect Immun. 1997 Dec;65(12):5222-30 [9393819.001]
  • [Cites] Clin Microbiol Rev. 1998 Jan;11(1):142-201 [9457432.001]
  • [Cites] Infect Immun. 1999 May;67(5):2292-8 [10225886.001]
  • [Cites] Vet Res. 1999 Mar-Jun;30(2-3):235-57 [10367357.001]
  • [Cites] Vet Microbiol. 1999 Aug 31;68(3-4):209-17 [10510040.001]
  • [Cites] J Clin Microbiol. 2004 Nov;42(11):4937-46 [15528677.001]
  • [Cites] Microbiology. 2004 Nov;150(Pt 11):3631-45 [15528651.001]
  • [Cites] J Bacteriol. 2004 Dec;186(23):8058-65 [15547278.001]
  • [Cites] Vet Microbiol. 2005 Jan 5;105(1):37-45 [15607082.001]
  • [Cites] FEMS Microbiol Rev. 2005 Jan;29(1):83-98 [15652977.001]
  • [Cites] Infect Immun. 2005 Feb;73(2):965-71 [15664939.001]
  • [Cites] Int Microbiol. 2004 Dec;7(4):269-76 [15666247.001]
  • [Cites] J Vet Diagn Invest. 2005 Jan;17(1):65-7 [15690954.001]
  • [Cites] Infect Immun. 2005 Mar;73(3):1735-43 [15731074.001]
  • [Cites] Vet Microbiol. 2005 Mar 20;106(1-2):87-95 [15737477.001]
  • [Cites] J Clin Microbiol. 2005 Mar;43(3):1366-71 [15750109.001]
  • [Cites] Emerg Infect Dis. 2005 Apr;11(4):603-9 [15829201.001]
  • [Cites] Vet Immunol Immunopathol. 2007 Dec 15;120(3-4):69-79 [17686530.001]
  • [Cites] J Clin Invest. 2007 Nov;117(11):3519-29 [17948128.001]
  • [Cites] Vet Microbiol. 2008 Jan 25;126(4):345-55 [17764859.001]
  • [Cites] Environ Microbiol. 2008 Mar;10(3):589-604 [18237301.001]
  • [Cites] Appl Environ Microbiol. 2008 Feb;74(4):1087-93 [18083855.001]
  • [Cites] Vaccine. 2008 Apr 16;26(17):2154-63 [18543416.001]
  • [Cites] Microbiology. 2008 Jul;154(Pt 7):2025-36 [18599831.001]
  • [Cites] Int J Med Microbiol. 2008 Oct;298(7-8):571-8 [18272428.001]
  • [Cites] J Bacteriol. 2009 Jan;191(1):411-21 [18952791.001]
  • [Cites] Appl Environ Microbiol. 2009 Jan;75(1):64-71 [18978078.001]
  • [Cites] Med Dosw Mikrobiol. 2008;60(3):173-81 [19143170.001]
  • [Cites] Infect Immun. 2009 Feb;77(2):783-90 [19064636.001]
  • [Cites] Vet J. 2009 Apr;180(1):124-9 [18077196.001]
  • [Cites] Acta Clin Belg. 2009 Jan-Feb;64(1):59-64 [19317243.001]
  • [Cites] J Clin Microbiol. 2009 Jul;47(7):2090-6 [19403767.001]
  • [Cites] FEMS Microbiol Lett. 2009 Aug;297(2):137-49 [19527295.001]
  • [Cites] Microbiology. 2010 Apr;156(Pt 4):1155-66 [20056708.001]
  • (PMID = 20423697.001).
  • [ISSN] 0928-4249
  • [Journal-full-title] Veterinary research
  • [ISO-abbreviation] Vet. Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] France
  • [Other-IDs] NLM/ PMC2881418
  •  go-up   go-down


10. |||....... 28%  Harmidy K, Tufenkji N, Gruenheid S: Perturbation of host cell cytoskeleton by cranberry proanthocyanidins and their effect on enteric infections. PLoS One; 2011;6(11):e27267
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In this study, the effect of cranberry proanthocyanidins (CPACs) on the infection of epithelial cells by two enteric bacterial pathogens, enteropathogenic Escherichia coli (EPEC) and Salmonella Typhimurium was investigated.
  • Immunofluorescence data showed that actin pedestal formation, required for infection by enteropathogenic Escherichia coli (EPEC), was disrupted in the presence of CPACs.
  • [MeSH-major] Actins / metabolism. Cytoskeleton / drug effects. Enteropathogenic Escherichia coli / drug effects. Epithelial Cells / drug effects. Proanthocyanidins / pharmacology. Salmonella typhimurium / drug effects. Vaccinium macrocarpon / chemistry
  • [MeSH-minor] Bacterial Adhesion. Bacterial Proteins / metabolism. Cell Survival / drug effects. Escherichia coli Infections / drug therapy. Escherichia coli Infections / microbiology. HeLa Cells. Humans. Salmonella Infections / drug therapy. Salmonella Infections / microbiology. Signal Transduction

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Mol Nutr Food Res. 2007 Jun;51(6):732-7 [17487930.001]
  • [Cites] Immunol Cell Biol. 2007 Feb-Mar;85(2):112-8 [17146467.001]
  • [Cites] Dalton Trans. 2007 Nov 21;(43):4951-61 [17992280.001]
  • [Cites] Nutr Rev. 2007 Nov;65(11):490-502 [18038941.001]
  • [Cites] J Agric Food Chem. 2008 Feb 13;56(3):676-80 [18211022.001]
  • [Cites] Mol Nutr Food Res. 2008 Jun;52 Suppl 1:S18-27 [18504707.001]
  • [Cites] J Agric Food Chem. 2008 Aug 27;56(16):6959-66 [18636738.001]
  • [Cites] Langmuir. 2008 Sep 16;24(18):10273-81 [18698853.001]
  • [Cites] J Gastroenterol Hepatol. 2008 Dec;23 Suppl 2:S175-80 [19120894.001]
  • [Cites] J Agric Food Chem. 2009 Jan 28;57(2):762-8 [19108687.001]
  • [Cites] Curr Opin Microbiol. 2009 Feb;12(1):117-24 [19157959.001]
  • [Cites] J Med Food. 2009 Apr;12(2):259-70 [19257836.001]
  • [Cites] Inflamm Res. 2009 Sep;58(9):537-52 [19381780.001]
  • [Cites] Mol Nutr Food Res. 2009 Sep;53 Suppl 2:S310-29 [19437486.001]
  • [Cites] Nat Rev Microbiol. 2010 Jan;8(1):26-38 [19966814.001]
  • [Cites] Int J Food Microbiol. 2010 Apr 30;139(1-2):102-7 [20153540.001]
  • [Cites] Crit Rev Food Sci Nutr. 2009 Oct;49(9):741-81 [20443158.001]
  • [Cites] Int J Food Microbiol. 2010 Jun 15;140(2-3):109-16 [20471125.001]
  • [Cites] Biofactors. 2010 May-Jun;36(3):159-68 [20232344.001]
  • [Cites] J Appl Microbiol. 2010 Aug;109(2):515-27 [20163489.001]
  • [Cites] Food Microbiol. 2010 Dec;27(8):985-91 [20832675.001]
  • [Cites] J Nutr. 2011 Jan;141(1):87-94 [21068182.001]
  • [Cites] Appl Environ Microbiol. 2011 Feb;77(4):1532-5 [21169441.001]
  • [Cites] J Nat Prod. 2011 Feb 25;74(2):113-8 [21275387.001]
  • [Cites] Appl Environ Microbiol. 2011 May;77(9):3061-7 [21378043.001]
  • [Cites] Appl Environ Microbiol. 2011 Oct;77(19):6852-7 [21821749.001]
  • [Cites] Phytochemistry. 2000 May;54(2):173-81 [10872208.001]
  • [Cites] J Biol Chem. 2002 May 24;277(21):18753-62 [11821396.001]
  • [Cites] Crit Rev Food Sci Nutr. 2002;42(3 Suppl):279-84 [12058986.001]
  • [Cites] JAMA. 2002 Jun 19;287(23):3082-3 [12069670.001]
  • [Cites] Mol Microbiol. 2004 Mar;51(5):1233-49 [14982621.001]
  • [Cites] J Infect Dis. 1972 Oct;126(4):378-86 [4403914.001]
  • [Cites] Lancet. 1978 May 27;1(8074):1119-22 [77415.001]
  • [Cites] J Biol Chem. 1981 May 10;256(9):4494-7 [7217094.001]
  • [Cites] Nature. 1981 May 21;291(5812):238-9 [7015147.001]
  • [Cites] Infect Immun. 1983 Sep;41(3):1340-51 [6350186.001]
  • [Cites] Infect Immun. 1989 Apr;57(4):1290-8 [2647635.001]
  • [Cites] Clin Microbiol Rev. 1998 Jan;11(1):142-201 [9457432.001]
  • [Cites] Helicobacter. 2005 Apr;10(2):139-45 [15810945.001]
  • [Cites] Phytochemistry. 2005 Sep;66(18):2281-91 [16055161.001]
  • [Cites] J Antimicrob Chemother. 2006 Aug;58(2):439-43 [16735419.001]
  • [Cites] Free Radic Biol Med. 2006 Dec 15;41(12):1727-46 [17157175.001]
  • [Cites] Mol Nutr Food Res. 2007 Jun;51(6):692-701 [17492799.001]
  • (PMID = 22076143.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Actins; 0 / Bacterial Proteins; 0 / Proanthocyanidins
  • [Other-IDs] NLM/ PMC3208605
  •  go-up   go-down


11. |||....... 32%  Girard F, Crepin VF, Frankel G: Modelling of infection by enteropathogenic Escherichia coli strains in lineages 2 and 4 ex vivo and in vivo by using Citrobacter rodentium expressing TccP. Infect Immun; 2009 Apr;77(4):1304-14
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Modelling of infection by enteropathogenic Escherichia coli strains in lineages 2 and 4 ex vivo and in vivo by using Citrobacter rodentium expressing TccP.
  • Enteropathogenic Escherichia coli (EPEC) strains colonize the human gut mucosa via attaching-and-effacing (A/E) lesion formation, while in vitro they employ diverse strategies to trigger actin polymerization.
  • Since mice are resistant to EPEC infection, in vivo studies are frequently done using the murine model pathogen Citrobacter rodentium, which shares with EPEC-1 strains the ability to induce A/E lesions and trigger strong actin polymerization via the Tir:Nck pathway.
  • Using a mouse intestinal in vitro organ culture model and oral gavage into C57BL/6 mice, we have shown that TccP can cooperate with Tir of C. rodentium.
  • [MeSH-major] Citrobacter rodentium / pathogenicity. Disease Models, Animal. Enteropathogenic Escherichia coli / pathogenicity. Escherichia coli Infections. Escherichia coli Proteins / metabolism

  • MedlinePlus Health Information. consumer health - E. Coli Infections.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Infect Immun. 1987 Jan;55(1):69-77 [3539808.001]
  • [Cites] Cell Microbiol. 2004 Oct;6(10):963-72 [15339271.001]
  • [Cites] Infect Immun. 1993 Nov;61(11):4654-61 [8406863.001]
  • [Cites] Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1664-8 [7878036.001]
  • [Cites] Infect Immun. 1996 Nov;64(11):4826-9 [8890245.001]
  • [Cites] Cell. 1997 Nov 14;91(4):511-20 [9390560.001]
  • [Cites] Mol Microbiol. 1998 Dec;30(5):911-21 [9988469.001]
  • [Cites] Mol Microbiol. 1999 Feb;31(4):1229-41 [10096089.001]
  • [Cites] Mol Microbiol. 1999 Apr;32(1):151-8 [10216868.001]
  • [Cites] Cell Microbiol. 2004 Dec;6(12):1167-83 [15527496.001]
  • [Cites] Mol Microbiol. 2005 Apr;56(2):416-32 [15813734.001]
  • [Cites] Infect Immun. 2005 May;73(5):2573-85 [15845459.001]
  • [Cites] Cell Microbiol. 2005 Aug;7(8):1163-72 [16008583.001]
  • [Cites] Infect Immun. 2005 Sep;73(9):5514-23 [16113267.001]
  • [Cites] Cell Microbiol. 2005 Dec;7(12):1697-706 [16309456.001]
  • [Cites] Curr Opin Microbiol. 2006 Feb;9(1):40-5 [16406772.001]
  • [Cites] Cell Microbiol. 2006 Jun;8(6):999-1008 [16681840.001]
  • [Cites] Cell Microbiol. 2006 Sep;8(9):1488-503 [16922867.001]
  • [Cites] Infect Immun. 2006 Nov;74(11):6196-205 [16954405.001]
  • [Cites] FEMS Microbiol Lett. 2006 Dec;265(1):126-32 [17034412.001]
  • [Cites] J Bacteriol. 2007 Jan;189(2):342-50 [17098897.001]
  • [Cites] Infect Immun. 2007 Feb;75(2):604-12 [17101643.001]
  • [Cites] Cell Microbiol. 2007 May;9(5):1352-64 [17474908.001]
  • [Cites] Appl Environ Microbiol. 2007 May;73(9):3084-90 [17351088.001]
  • [Cites] Microbiology. 2007 Jun;153(Pt 6):1743-55 [17526832.001]
  • [Cites] Cell Microbiol. 2007 Sep;9(9):2242-53 [17521329.001]
  • [Cites] Cell Microbiol. 2008 Mar;10(3):549-56 [18053003.001]
  • [Cites] FEMS Microbiol Lett. 2008 Jun;283(2):196-202 [18422621.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6640-5 [10829079.001]
  • [Cites] Trends Microbiol. 2001 May;9(5):214-8 [11336837.001]
  • [Cites] Nat Cell Biol. 2001 Sep;3(9):856-9 [11533668.001]
  • [Cites] Mol Microbiol. 2002 Mar;43(5):1227-41 [11918809.001]
  • [Cites] Infect Immun. 2003 Apr;71(4):2262-5 [12654853.001]
  • [Cites] Mol Microbiol. 2003 May;48(3):795-809 [12694622.001]
  • [Cites] Mol Microbiol. 2004 Jan;51(1):73-87 [14651612.001]
  • [Cites] Nat Rev Microbiol. 2004 Feb;2(2):123-40 [15040260.001]
  • [Cites] Dev Cell. 2004 Aug;7(2):217-28 [15296718.001]
  • [Cites] Proc Natl Acad Sci U S A. 1990 Oct;87(20):7839-43 [2172966.001]
  • (PMID = 19188355.001).
  • [ISSN] 1098-5522
  • [Journal-full-title] Infection and immunity
  • [ISO-abbreviation] Infect. Immun.
  • [Language] eng
  • [Grant] United Kingdom / Biotechnology and Biological Sciences Research Council / / ; United Kingdom / Wellcome Trust / /
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Actins; 0 / Escherichia coli Proteins; 0 / tccP protein, E coli
  • [Other-IDs] NLM/ PMC2663131
  •  go-up   go-down


12. |||....... 29%  Shui JW, Larange A, Kim G, Vela JL, Zahner S, Cheroutre H, Kronenberg M: HVEM signalling at mucosal barriers provides host defence against pathogenic bacteria. Nature; 2012 Aug 9;488(7410):222-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • During intestinal Citrobacter rodentium infection, a mouse model for enteropathogenic Escherichia coli infection, Hvem−/− mice showed decreased Stat3 activation, impaired responses in the colon, higher bacterial burdens and increased mortality.
  • Likewise, in pulmonary Streptococcus pneumoniae infection, HVEM is also required for host defence.
  • [MeSH-minor] Animals. Antigens, CD / immunology. Antigens, CD / metabolism. Bacterial Load. Cell Line. Disease Models, Animal. Enterobacteriaceae Infections / immunology. Enterobacteriaceae Infections / microbiology. Enteropathogenic Escherichia coli. Epithelial Cells / immunology. Epithelial Cells / metabolism. Escherichia coli Infections. GPI-Linked Proteins / immunology. GPI-Linked Proteins / metabolism. Intestines / immunology. Intestines / microbiology. Ligands. Lung / immunology. Lung / microbiology. Lymphocytes / immunology. Lymphocytes / metabolism. Mice. Mice, Inbred C57BL. Pneumococcal Infections / immunology. Pneumococcal Infections / microbiology. Protein-Serine-Threonine Kinases / metabolism. Receptors, Immunologic / immunology. Receptors, Immunologic / metabolism. STAT3 Transcription Factor / metabolism. Streptococcus pneumoniae / immunology. Survival Rate

  • Faculty of 1000. See the articles recommended by F1000Prime's Faculty of more than 5,000 expert scientists and clinical researchers. (subscription/membership/fee required).
  • KOMP Repository. gene/protein/disease-specific - KOMP Repository (subscription/membership/fee required).
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Exp Med. 2011 Aug 29;208(9):1917-29 [21807870.001]
  • [Cites] PLoS One. 2011;6(4):e18495 [21533159.001]
  • [Cites] J Biol Chem. 2000 May 12;275(19):14307-15 [10799510.001]
  • [Cites] Genes Immun. 2003 Mar;4(2):153-9 [12618864.001]
  • [Cites] Immunity. 2004 Aug;21(2):241-54 [15308104.001]
  • [Cites] J Biol Chem. 1997 May 30;272(22):14029-32 [9162022.001]
  • [Cites] J Immunol. 1998 Sep 15;161(6):2780-90 [9743336.001]
  • [Cites] Nat Genet. 1999 May;22(1):74-7 [10319865.001]
  • [Cites] J Immunol. 2005 Oct 1;175(7):4426-32 [16177084.001]
  • [Cites] Cell Microbiol. 2005 Dec;7(12):1697-706 [16309456.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2006 Apr;290(4):G827-38 [16537974.001]
  • [Cites] Microbes Infect. 2007 Mar;9(3):364-74 [17314060.001]
  • [Cites] J Immunol. 2007 Feb 1;178(3):1896-903 [17237440.001]
  • [Cites] Cell Microbiol. 2006 Oct;8(10):1669-86 [16759225.001]
  • [Cites] J Clin Invest. 2008 Feb;118(2):534-44 [18172556.001]
  • [Cites] Nat Med. 2008 Mar;14(3):282-9 [18264109.001]
  • [Cites] Am J Physiol Lung Cell Mol Physiol. 2008 Mar;294(3):L387-98 [18162603.001]
  • [Cites] Cell Host Microbe. 2008 Mar 13;3(3):146-57 [18329614.001]
  • [Cites] Am J Respir Cell Mol Biol. 2008 Jun;38(6):699-706 [18192501.001]
  • [Cites] Nat Rev Immunol. 2008 Jun;8(6):411-20 [18469830.001]
  • [Cites] J Exp Med. 2008 Jun 9;205(6):1463-76 [18519647.001]
  • [Cites] Immunity. 2008 Dec 19;29(6):947-57 [19100701.001]
  • [Cites] Immunity. 2009 Jan 16;30(1):108-19 [19144317.001]
  • [Cites] Infect Immun. 2009 Feb;77(2):604-14 [19075023.001]
  • [Cites] Nature. 2009 Mar 5;458(7234):78-82 [19262671.001]
  • [Cites] Proc Natl Acad Sci U S A. 2009 Apr 14;106(15):6244-9 [19332782.001]
  • [Cites] Blood. 2009 Jun 25;113(26):6603-10 [19411637.001]
  • [Cites] J Exp Med. 2009 Jul 6;206(7):1465-72 [19564350.001]
  • [Cites] Semin Immunopathol. 2010 Mar;32(1):17-31 [20127093.001]
  • [Cites] Annu Rev Immunol. 2010;28:389-411 [20307212.001]
  • [Cites] Immunity. 2010 Mar 26;32(3):379-91 [20303296.001]
  • [Cites] Cell Tissue Res. 2011 Jan;343(1):153-65 [20872151.001]
  • [Cites] Nat Genet. 2011 Mar;43(3):246-52 [21297633.001]
  • [Cites] J Exp Med. 2006 Oct 2;203(10):2271-9 [16982811.001]
  • (PMID = 22801499.001).
  • [ISSN] 1476-4687
  • [Journal-full-title] Nature
  • [ISO-abbreviation] Nature
  • [Language] eng
  • [Grant] United States / NIAID NIH HHS / AI / F32 AI083029; United States / NIDDK NIH HHS / DK / F32 DK082249; United States / NIAID NIH HHS / AI / F32-AI083029; United States / NIDDK NIH HHS / DK / F32-DK082249; United States / NIDDK NIH HHS / DK / P01 DK046763; United States / NIDDK NIH HHS / DK / P01 DK46763; United States / NIAID NIH HHS / AI / R01 AI050265; United States / NIAID NIH HHS / AI / R01 AI061516; United States / NIAID NIH HHS / AI / R01 AI064584; United States / NIAID NIH HHS / AI / R01-AI061516
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / Cd160 protein, mouse; 0 / GPI-Linked Proteins; 0 / Ligands; 0 / Receptors, Immunologic; 0 / Receptors, Tumor Necrosis Factor, Member 14; 0 / STAT3 Transcription Factor; 0 / Stat3 protein, mouse; 0 / Tnfrsf14 protein, mouse; EC 2.7.11.1 / Protein-Serine-Threonine Kinases; EC 2.7.11.25 / NF-kappa B kinase
  • [Other-IDs] NLM/ NIHMS406607; NLM/ PMC3477500
  •  go-up   go-down


13. |||....... 29%  Esmaili A, Nazir SF, Borthakur A, Yu D, Turner JR, Saksena S, Singla A, Hecht GA, Alrefai WA, Gill RK: Enteropathogenic Escherichia coli infection inhibits intestinal serotonin transporter function and expression. Gastroenterology; 2009 Dec;137(6):2074-83
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Enteropathogenic Escherichia coli infection inhibits intestinal serotonin transporter function and expression.
  • Whether alteration in SERT activity contributes to the pathophysiology of diarrhea induced by the food-borne pathogen enteropathogenic Escherichia coli (EPEC) is not known.
  • The present studies examined the effects of EPEC infection on SERT activity and expression in intestinal epithelial cells and elucidated the underlying mechanisms.
  • METHODS: Caco-2 cells as a model of human intestinal epithelia and EPEC-infected C57BL/6J mouse model of infection were utilized.
  • RESULTS: Infection of Caco-2 cells with EPEC for 30-120 minutes decreased apical SERT activity (P < .001) in a type 3 secretion system dependent manner and via involvement of protein tyrosine phosphatases.
  • EPEC infection decreased V(max) of the transporter; whereas cell surface biotinylation studies revealed no alteration in the cellular or plasma membrane content of SERT in Caco-2 cells.
  • EPEC infection of mice (24 hours) reduced SERT immunostaining with a corresponding decrease in SERT messenger RNA levels, 5-HT uptake, and mucosal 5-HT content in the small intestine.
  • [MeSH-major] Enteropathogenic Escherichia coli / pathogenicity. Escherichia coli Infections / metabolism. Intestinal Mucosa / metabolism. Intestine, Small / metabolism. Serotonin / metabolism. Serotonin Plasma Membrane Transport Proteins / metabolism

  • MedlinePlus Health Information. consumer health - E. Coli Infections.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Mol Microbiol. 1997 Jan;23(2):399-407 [9044273.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2008 Jan;294(1):G254-62 [17991706.001]
  • [Cites] Infect Immun. 1997 Jul;65(7):2528-36 [9199415.001]
  • [Cites] Gene. 1997 Jun 11;192(1):33-8 [9224871.001]
  • [Cites] Am J Physiol. 1998 Sep;275(3 Pt 1):G433-48 [9724254.001]
  • [Cites] Mol Microbiol. 1998 Dec;30(5):911-21 [9988469.001]
  • [Cites] Am J Physiol. 1999 Oct;277(4 Pt 1):C645-51 [10516094.001]
  • [Cites] J Neurosci. 2005 Jan 5;25(1):29-41 [15634764.001]
  • [Cites] Infect Immun. 2005 Feb;73(2):1161-70 [15664959.001]
  • [Cites] J Biol Chem. 2005 Mar 25;280(12):11859-68 [15637072.001]
  • [Cites] Gastroenterology. 2005 Apr;128(4):962-74 [15825078.001]
  • [Cites] Mol Pharmacol. 2005 Jun;67(6):2077-87 [15774771.001]
  • [Cites] Infect Immun. 2005 Jul;73(7):4327-37 [15972527.001]
  • [Cites] Am J Physiol Cell Physiol. 2005 Oct;289(4):C846-52 [15901598.001]
  • [Cites] Lab Invest. 2005 Oct;85(10):1308-24 [16127426.001]
  • [Cites] Neurogastroenterol Motil. 2005 Dec;17(6):863-70 [16336502.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2006 Jan;290(1):G30-5 [16150873.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Feb 7;103(6):1876-81 [16446436.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2006 Apr;290(4):G685-94 [16322091.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2006 Nov;291(5):G959-68 [16782696.001]
  • [Cites] J Clin Invest. 2007 Feb;117(2):428-37 [17256057.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2007 Mar;292(3):G779-84 [17170025.001]
  • [Cites] Life Sci. 2007 Mar 27;80(16):1517-24 [17289086.001]
  • [Cites] Drug Metab Dispos. 2007 Apr;35(4):590-4 [17220238.001]
  • [Cites] Acta Physiol (Oxf). 2008 May;193(1):57-65 [18081886.001]
  • [Cites] J Nutr. 2008 Jul;138(7):1355-9 [18567760.001]
  • [Cites] Cell Microbiol. 2008 Aug;10(8):1735-45 [18433466.001]
  • [Cites] Genome Biol. 2008;9(8):R122 [18680595.001]
  • [Cites] Annu Rev Cell Dev Biol. 2000;16:173-89 [11031234.001]
  • [Cites] Cell Microbiol. 2000 Oct;2(5):401-14 [11207596.001]
  • [Cites] Cell Microbiol. 2000 Dec;2(6):579-90 [11207610.001]
  • [Cites] J Clin Invest. 2001 Mar;107(5):621-9 [11238563.001]
  • [Cites] EMBO J. 2001 Mar 15;20(6):1245-58 [11250891.001]
  • [Cites] Infect Immun. 2001 Jun;69(6):4027-33 [11349072.001]
  • [Cites] Digestion. 2001;63(3):188-94 [11351146.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2001 Jul;281(1):G1-7 [11408249.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11638-43 [11562461.001]
  • [Cites] Am J Physiol Cell Physiol. 2001 Nov;281(5):C1533-41 [11600416.001]
  • [Cites] Cell Microbiol. 2001 Dec;3(12):865-71 [11736997.001]
  • [Cites] Mol Microbiol. 2003 Feb;47(3):595-606 [12535063.001]
  • [Cites] Infect Immun. 2003 Jun;71(6):3310-9 [12761113.001]
  • [Cites] J Pharmacol Exp Ther. 2003 Jul;306(1):355-62 [12682218.001]
  • [Cites] Am J Physiol Cell Physiol. 2003 Nov;285(5):C1219-25 [12867360.001]
  • [Cites] Am J Gastroenterol. 2003 Dec;98(12):2705-11 [14687821.001]
  • [Cites] Microbes Infect. 2004 Jan;6(1):38-50 [14738892.001]
  • [Cites] BMC Pharmacol. 2004 Feb 6;4:1 [15018640.001]
  • [Cites] Gastroenterology. 2004 Jun;126(7):1657-64 [15188158.001]
  • [Cites] J Pharmacol Exp Ther. 2004 Jul;310(1):1-7 [15064332.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2004 Aug;287(2):G370-8 [15075254.001]
  • [Cites] Am J Gastroenterol. 1966 Jul;46(1):34-7 [5944925.001]
  • [Cites] Biochim Biophys Acta. 1973 Sep 27;323(1):98-112 [4356391.001]
  • [Cites] Biochim Biophys Acta. 1980 Oct 2;601(3):592-604 [6106503.001]
  • [Cites] Methods Enzymol. 1988;156:105-15 [2835596.001]
  • [Cites] Kidney Int. 1988 Sep;34(3):309-20 [3050247.001]
  • [Cites] J Pharmacol Exp Ther. 1995 Mar;272(3):1151-9 [7891327.001]
  • [Cites] Mol Microbiol. 1996 Aug;21(3):633-41 [8866485.001]
  • [Cites] Trends Microbiol. 1997 Mar;5(3):109-14 [9080609.001]
  • (PMID = 19747920.001).
  • [ISSN] 1528-0012
  • [Journal-full-title] Gastroenterology
  • [ISO-abbreviation] Gastroenterology
  • [Language] eng
  • [Grant] United States / NIDDK NIH HHS / DK / DK 061931; United States / NIDDK NIH HHS / DK / DK-074459; United States / NIDDK NIH HHS / DK / DK-09930; United States / NIDDK NIH HHS / DK / DK068271; United States / NIDDK NIH HHS / DK / K01 DK074458; United States / NIDDK NIH HHS / DK / P01 DK-067887; United States / NIDDK NIH HHS / DK / R01 DK071596
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / RNA, Messenger; 0 / SLC6A4 protein, human; 0 / Serotonin Plasma Membrane Transport Proteins; 0 / Slc6a4 protein, mouse; 333DO1RDJY / Serotonin; EC 3.1.3.48 / Protein Tyrosine Phosphatases
  • [Other-IDs] NLM/ NIHMS145181; NLM/ PMC3727418
  •  go-up   go-down


14. |||....... 28%  Dean P, Kenny B: Cell-surface nucleolin is sequestered into EPEC microcolonies and may play a role during infection. Microbiology; 2011 Jun;157(Pt 6):1761-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cell-surface nucleolin is sequestered into EPEC microcolonies and may play a role during infection.
  • Nucleolin is a prominent nucleolar protein that is mobilized into the cytoplasm during infection by enteropathogenic Escherichia coli (EPEC).
  • Nucleolin also exists at low levels at the cell surface of eukaryotic cells and here we show that upon infection of an intestinal cell model, EPEC recruits and subsequently sequesters cell-surface EGFP-nucleolin into extracellularly located bacterial microcolonies.
  • Incubation of host intestinal cells with different ligands that specifically bind nucleolin impaired the ability of EPEC to disrupt epithelial barrier function but did not inhibit bacterial attachment or other effector-driven processes such as pedestal formation or microvilli effacement.
  • Taken together, this work suggests that EPEC exploits two spatially distinct pools of nucleolin during the infection process.
  • [MeSH-major] Enteropathogenic Escherichia coli / growth & development. Enteropathogenic Escherichia coli / pathogenicity. Intestine, Small / microbiology. Phosphoproteins / metabolism. RNA-Binding Proteins / metabolism

  • COS Scholar Universe. author profiles.
  • ExactAntigen/Labome. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Exp Cell Res. 2000 Dec 15;261(2):312-28 [11112338.001]
  • [Cites] FASEB J. 1999 Nov;13(14):1911-22 [10544174.001]
  • [Cites] J Biol Chem. 2002 Jan 25;277(4):2876-85 [11704679.001]
  • [Cites] J Biol Chem. 2002 Oct 4;277(40):37492-502 [12147681.001]
  • [Cites] Cell Microbiol. 2003 Jun;5(6):359-72 [12780774.001]
  • [Cites] J Cell Biol. 2003 Nov 24;163(4):871-8 [14638862.001]
  • [Cites] J Biol Chem. 2004 Aug 6;279(32):33751-8 [15173179.001]
  • [Cites] Mol Microbiol. 2004 Nov;54(3):665-75 [15491358.001]
  • [Cites] Arch Biochem Biophys. 1991 Nov 1;290(2):320-5 [1834017.001]
  • [Cites] J Biochem. 1994 Nov;116(5):1063-8 [7896734.001]
  • [Cites] Biochim Biophys Acta. 1995 Apr 6;1266(1):109-12 [7718615.001]
  • [Cites] J Virol. 1995 Nov;69(11):6751-7 [7474086.001]
  • [Cites] Cell. 1997 Nov 14;91(4):511-20 [9390560.001]
  • [Cites] J Cell Sci. 1999 Mar;112 ( Pt 6):761-72 [10036227.001]
  • [Cites] J Biol Chem. 1999 Sep 24;274(39):27875-84 [10488134.001]
  • [Cites] FEBS J. 2005 Sep;272(18):4646-59 [16156786.001]
  • [Cites] Infect Immun. 2006 Feb;74(2):1255-65 [16428775.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Feb 7;103(6):1876-81 [16446436.001]
  • [Cites] Cell Res. 2006 Feb;16(2):174-81 [16474431.001]
  • [Cites] Subcell Biochem. 2007;41:125-44 [17484127.001]
  • [Cites] BMC Mol Biol. 2007;8:66 [17692122.001]
  • [Cites] Exp Cell Res. 2008 Jul 1;314(11-12):2212-23 [18504038.001]
  • [Cites] Exp Cell Res. 2009 Jan 15;315(2):357-69 [19026635.001]
  • [Cites] Curr Opin Microbiol. 2009 Feb;12(1):101-9 [19144561.001]
  • [Cites] FEMS Microbiol Rev. 2005 Jan;29(1):83-98 [15652977.001]
  • [Cites] Biol Pharm Bull. 2010;33(5):796-803 [20460757.001]
  • [Cites] PLoS Pathog. 2010;6(6):e1000961 [20585567.001]
  • [Cites] Infect Immun. 2010 Nov;78(11):4445-53 [20679436.001]
  • [Cites] J Cell Biol. 2001 Apr 2;153(1):169-76 [11285283.001]
  • (PMID = 21436219.001).
  • [ISSN] 1465-2080
  • [Journal-full-title] Microbiology (Reading, England)
  • [ISO-abbreviation] Microbiology (Reading, Engl.)
  • [Language] eng
  • [Grant] United Kingdom / Wellcome Trust / /
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Phosphoproteins; 0 / RNA-Binding Proteins; 0 / enhanced green fluorescent protein; 0 / nucleolin; 147336-22-9 / Green Fluorescent Proteins
  • [Other-IDs] NLM/ PMC3167913
  •  go-up   go-down


15. |||....... 28%  Liu Z, Ma Y, Moyer MP, Zhang P, Shi C, Qin H: Involvement of the mannose receptor and p38 mitogen-activated protein kinase signaling pathway of the microdomain of the integral membrane protein after enteropathogenic Escherichia coli infection. Infect Immun; 2012 Apr;80(4):1343-50
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Involvement of the mannose receptor and p38 mitogen-activated protein kinase signaling pathway of the microdomain of the integral membrane protein after enteropathogenic Escherichia coli infection.
  • The microdomain of the integral membrane protein (MIMP) has been shown to adhere to mucin and to antagonize the adhesion of enteropathogenic Escherichia coli (EPEC) to epithelial cells; however, the mechanism has not been fully elucidated.
  • The results indicated that MIMP adhered to NCM460 cells by binding to the mannose receptor and inhibited the phosphorylation of p38 MAPK stimulated after EPEC infection via inhibition of the Toll-like receptor 5 pathway.
  • These findings indicated that MIMPs relieve the injury of NCM460 cells after enteropathogenic E. coli infection through the mannose receptor and inhibition of the p38 MAPK signaling pathway, both of which may therefore be potential therapeutic targets for intestinal diseases, such as inflammatory bowel disease.
  • [MeSH-major] Enteropathogenic Escherichia coli / pathogenicity. Escherichia coli Infections / metabolism. Escherichia coli Proteins / metabolism. Lectins, C-Type / metabolism. MAP Kinase Signaling System. Mannose-Binding Lectins / metabolism. Membrane Proteins / metabolism. Receptors, Cell Surface / metabolism. p38 Mitogen-Activated Protein Kinases / metabolism

  • MedlinePlus Health Information. consumer health - E. Coli Infections.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Bacteriol. 2000 Feb;182(4):859-68 [10648507.001]
  • [Cites] Infect Immun. 2011 Jan;79(1):185-91 [20974822.001]
  • [Cites] Gastroenterology. 2001 Sep;121(3):580-91 [11522742.001]
  • [Cites] Am J Pathol. 2001 Dec;159(6):2001-9 [11733350.001]
  • [Cites] Gastroenterology. 2002 Jan;122(1):44-54 [11781279.001]
  • [Cites] J Neurosci Res. 2002 Mar 1;67(5):566-73 [11891769.001]
  • [Cites] Crit Care Med. 2003 Feb;31(2):598-607 [12576972.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2004 Feb;286(2):G244-52 [14715519.001]
  • [Cites] Nat Rev Microbiol. 2004 Feb;2(2):123-40 [15040260.001]
  • [Cites] Gastroenterology. 2004 May;126(6):1620-33 [15168372.001]
  • [Cites] Gut. 1994 Apr;35(4):483-9 [8174985.001]
  • [Cites] Circ Res. 1995 Sep;77(3):494-502 [7543826.001]
  • [Cites] J Clin Invest. 1997 Mar 1;99(5):975-86 [9062356.001]
  • [Cites] J Immunol. 1997 Apr 1;158(7):3433-8 [9120304.001]
  • [Cites] J Clin Invest. 1997 Oct 1;100(7):1797-803 [9312180.001]
  • [Cites] J Biol Chem. 1998 Feb 6;273(6):3285-90 [9452444.001]
  • [Cites] J Biol Chem. 1998 Jun 12;273(24):15294-300 [9614146.001]
  • [Cites] J Leukoc Biol. 1998 Dec;64(6):835-44 [9850168.001]
  • [Cites] Lab Invest. 1999 Jan;79(1):49-57 [9952110.001]
  • [Cites] Lancet. 1999 Aug 21;354(9179):635-9 [10466665.001]
  • [Cites] Appl Environ Microbiol. 2005 Dec;71(12):8344-51 [16332821.001]
  • [Cites] Cell Microbiol. 2007 Feb;9(2):356-67 [16925785.001]
  • [Cites] J Nutr. 2007 Mar;137(3 Suppl 2):798S-802S [17311978.001]
  • [Cites] Gut. 2007 May;56(5):610-2 [17440180.001]
  • [Cites] Front Biosci (Landmark Ed). 2011;16:2106-27 [21622165.001]
  • [Cites] Front Biosci (Landmark Ed). 2011;16:2128-43 [21622166.001]
  • [Cites] Mol Biol Rep. 2011 Feb;38(2):1353-61 [20571906.001]
  • [Cites] Cell Physiol Biochem. 2011;27(1):99-108 [21325827.001]
  • [Cites] Mol Biol Rep. 2011 Jun;38(5):3471-80 [21086172.001]
  • [Cites] Front Biosci (Landmark Ed). 2011;16:2903-9 [21622211.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 2011 Aug;53(2):174-81 [21788759.001]
  • [Cites] Infect Immun. 2011 Sep;79(9):3552-62 [21746856.001]
  • [Cites] Ann Surg. 2011 Nov;254(5):832-3; author reply 833 [22005146.001]
  • [Cites] J Immunol. 1998 Aug 15;161(4):1921-9 [9712062.001]
  • [Cites] Gut. 2007 Sep;56(9):1240-7 [17456510.001]
  • [Cites] Gut. 2008 Mar;57(3):424-5 [18268057.001]
  • [Cites] Infect Immun. 2008 Apr;76(4):1410-22 [18227166.001]
  • [Cites] Nutr Rev. 2008 Apr;66(4):192-202 [18366533.001]
  • [Cites] Nat Rev Microbiol. 2008 May;6(5):349-62 [18345021.001]
  • [Cites] Curr Microbiol. 2008 Jul;57(1):33-8 [18379843.001]
  • [Cites] Front Biosci. 2008;13:6193-201 [18508653.001]
  • [Cites] BMC Microbiol. 2008;8:165 [18828902.001]
  • [Cites] Am J Gastroenterol. 2009 Feb;104(2):437-43 [19174792.001]
  • [Cites] Infect Immun. 2009 Mar;77(3):1031-43 [19075027.001]
  • [Cites] BMC Microbiol. 2009;9:63 [19331693.001]
  • [Cites] Nat Protoc. 2009;4(6):939-46 [19478809.001]
  • [Cites] Lancet. 2009 Jul 11;374(9684):136-44 [19595348.001]
  • [Cites] Infect Immun. 2010 May;78(5):2024-33 [20231411.001]
  • [Cites] Infect Immun. 2010 Jun;78(6):2812-22 [20308300.001]
  • [Cites] Infect Immun. 2010 Jul;78(7):3103-11 [20385752.001]
  • [Cites] Lancet. 2010 Jul 24;376(9737):233 [20656124.001]
  • [Cites] J Immunol. 2010 Aug 1;185(3):1522-31 [20610655.001]
  • [Cites] Infect Immun. 2010 Nov;78(11):4958-64 [20823198.001]
  • [Cites] BMC Med Genet. 2010;11:151 [21029423.001]
  • [Cites] World J Gastroenterol. 2010 Dec 7;16(45):5759-65 [21128328.001]
  • [Cites] Aliment Pharmacol Ther. 2011 Jan;33(1):50-63 [21083585.001]
  • [Cites] Am J Clin Nutr. 2001 Feb;73(2 Suppl):465S-470S [11157359.001]
  • (PMID = 22290149.001).
  • [ISSN] 1098-5522
  • [Journal-full-title] Infection and immunity
  • [ISO-abbreviation] Infect. Immun.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Escherichia coli Proteins; 0 / Lectins, C-Type; 0 / Mannose-Binding Lectins; 0 / Membrane Glycoproteins; 0 / Membrane Proteins; 0 / Receptors, Cell Surface; 0 / Toll-Like Receptor 5; 0 / mannose receptor; EC 2.7.11.24 / p38 Mitogen-Activated Protein Kinases
  • [Other-IDs] NLM/ PMC3318401
  •  go-up   go-down


16. |||....... 28%  Crane JK, Naeher TM, Broome JE, Boedeker EC: Role of host xanthine oxidase in infection due to enteropathogenic and Shiga-toxigenic Escherichia coli. Infect Immun; 2013 Apr;81(4):1129-39
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Role of host xanthine oxidase in infection due to enteropathogenic and Shiga-toxigenic Escherichia coli.
  • Here, we present evidence that XO is released from and active in intestinal tissues and fluids in response to infection with enteropathogenic Escherichia coli (EPEC) and Shiga-toxigenic E. coli (STEC), also known as enterohemorrhagic E. coli (EHEC).
  • XO is released into intestinal fluids in EPEC and STEC infection in a rabbit animal model.
  • XO activity results in the generation of surprisingly high concentrations of uric acid in both cultured cell and animal models of infection.
  • Hydrogen peroxide (H(2)O(2)) generated by XO activity triggered a chloride secretory response in intestinal cell monolayers within minutes but decreased transepithelial electrical resistance at 6 to 22 h.
  • H(2)O(2) generated by XO activity was effective at killing laboratory strains of E. coli, commensal microbiotas, and anaerobes, but wild-type EPEC and STEC strains were 100 to 1,000 times more resistant to killing or growth inhibition by this pathway.
  • In vivo, exogenous XO plus the substrate hypoxanthine did not protect and instead worsened the outcome of STEC infection in the rabbit ligated intestinal loop model of infection.
  • XO released during EPEC and STEC infection may serve as a virulence-inducing signal to the pathogen and not solely as a protective host defense.
  • [MeSH-major] Enteropathogenic Escherichia coli / pathogenicity. Escherichia coli Infections / pathology. Host-Pathogen Interactions. Shiga-Toxigenic Escherichia coli / pathogenicity. Xanthine Oxidase / metabolism

  • MedlinePlus Health Information. consumer health - E. Coli Infections.
  • HSDB. structure - HYDROGEN PEROXIDE.
  • ExactAntigen/Labome. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Infect Immun. 2000 Apr;68(4):2374-8 [10722648.001]
  • [Cites] J Dairy Sci. 1978 Feb;61(2):164-7 [641238.001]
  • [Cites] Lancet. 1978 May 27;1(8074):1119-22 [77415.001]
  • [Cites] Proc Natl Acad Sci U S A. 1978 Jun;75(6):2800-4 [26915.001]
  • [Cites] Gastroenterology. 1982 Aug;83(2):441-54 [7044882.001]
  • [Cites] Am J Dis Child. 1987 Feb;141(2):161-6 [3812382.001]
  • [Cites] J Gen Microbiol. 1987 Aug;133(8):2007-14 [3127535.001]
  • [Cites] Clin Nephrol. 1988 Oct;30(4):207-10 [3214966.001]
  • [Cites] Proc Natl Acad Sci U S A. 1990 Oct;87(20):7839-43 [2172966.001]
  • [Cites] Infect Immun. 1993 Jul;61(7):2755-62 [8514377.001]
  • [Cites] Biochem Pharmacol. 1994 Jan 20;47(2):403-10 [8304984.001]
  • [Cites] J Pediatr Surg. 1993 Sep;28(9):1175-7 [8308686.001]
  • [Cites] Am J Physiol. 1996 Apr;270(4 Pt 1):G634-45 [8928793.001]
  • [Cites] Mol Microbiol. 1996 Apr;20(1):87-100 [8861207.001]
  • [Cites] Infect Immun. 1997 Jul;65(7):2932-40 [9199469.001]
  • [Cites] J Pediatr. 1997 Jun;130(6):1013 [9202636.001]
  • [Cites] Biochem Soc Trans. 1997 Aug;25(3):750-5 [9388538.001]
  • [Cites] Vet Res. 1999 Mar-Jun;30(2-3):203-19 [10367355.001]
  • [Cites] Infect Immun. 2006 Mar;74(3):1505-15 [16495521.001]
  • [Cites] J Perinatol. 2007 Jul;27(7):428-33 [17443195.001]
  • [Cites] Infect Immun. 2007 Dec;75(12):5974-84 [17875638.001]
  • [Cites] Br J Pharmacol. 2008 Jul;154(5):991-1000 [18587445.001]
  • [Cites] Infect Immun. 2009 Feb;77(2):783-90 [19064636.001]
  • [Cites] FEMS Immunol Med Microbiol. 2009 Dec;57(3):214-28 [19751218.001]
  • [Cites] FEMS Immunol Med Microbiol. 2010 Apr;58(3):322-9 [20070366.001]
  • [Cites] Infect Immun. 2011 Apr;79(4):1696-705 [21245267.001]
  • [Cites] MBio. 2012;3(3). pii: e00050-12. doi: 10.1128/mBio.00050-12 [22589288.001]
  • [Cites] Pediatr Infect Dis J. 1996 Jul;15(7):642-3 [8823869.001]
  • [Cites] Nature. 2001 Jan 25;409(6819):529-33 [11206551.001]
  • [Cites] Infect Immun. 2001 Mar;69(3):1934-7 [11179378.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2002 Jul;283(1):G74-86 [12065294.001]
  • [Cites] Antimicrob Agents Chemother. 2002 Oct;46(10):3308-10 [12234868.001]
  • [Cites] Infect Immun. 2003 Mar;71(3):1557-60 [12595476.001]
  • [Cites] Infect Immun. 2004 Sep;72(9):4933-9 [15321984.001]
  • [Cites] Infect Immun. 2004 Sep;72(9):5446-51 [15322043.001]
  • [Cites] J Pediatr. 2004 Sep;145(3):297-303 [15343178.001]
  • [Cites] Nature. 1968 Mar 23;217(5134):1110-4 [4868368.001]
  • [Cites] Am J Dis Child. 1976 Aug;130(8):854-6 [941885.001]
  • [Cites] Lancet. 2000 Sep 2;356(9232):829-30 [11022933.001]
  • (PMID = 23340314.001).
  • [ISSN] 1098-5522
  • [Journal-full-title] Infection and immunity
  • [ISO-abbreviation] Infect. Immun.
  • [Language] eng
  • [Grant] United States / NIAID NIH HHS / AI / R01 AI 081528; United States / NIAID NIH HHS / AI / R21 AI 102212; United States / NIAID NIH HHS / AI / R21 AI102212
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 268B43MJ25 / Uric Acid; BBX060AN9V / Hydrogen Peroxide; EC 1.17.3.2 / Xanthine Oxidase
  • [Other-IDs] NLM/ PMC3639607
  •  go-up   go-down


17. |||....... 28%  Choi HJ, Kim J, Do KH, Park SH, Moon Y: Prolonged NF-κB activation by a macrophage inhibitory cytokine 1-linked signal in enteropathogenic Escherichia coli-infected epithelial cells. Infect Immun; 2013 Jun;81(6):1860-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Prolonged NF-κB activation by a macrophage inhibitory cytokine 1-linked signal in enteropathogenic Escherichia coli-infected epithelial cells.
  • Intestinal epithelial activation of nuclear factor kappa B (NF-κB) exerts both detrimental and beneficial functions in response to various luminal insults, including ones associated with mucosa-associated pathogens.
  • Gastrointestinal infection with enteropathogenic Escherichia coli (EPEC) causes severe injuries in epithelial integrity and leads to watery diarrhea.
  • The present study was conducted to investigate the prolonged epithelial responses to persistent EPEC infection via NF-κB activation.
  • EPEC infection led to sustained activation of NF-κB signal in mouse intestinal epithelial cells in vivo and in vitro, which was positively associated with a type III secretion system, whereas early NF-κB is regulated.
  • Moreover, prolonged NF-κB activation was found to be a part of macrophage inhibitory cytokine 1 (MIC-1)-mediated signaling activation, a novel link between NF-κB signaling and infection-associated epithelial stress.
  • EPEC infection induced gene expression of MIC-1, a member of the transforming growth factor β (TGF-β) superfamily, which then activated TGF-β-activated kinase 1 and consequently led to NF-κB activation.
  • In summary, the results of the present study suggest that MIC-1 serves as a mediator of prolonged NF-κB activation, which is critical in maintaining gut epithelial integrity in response to infection-induced injuries.
  • [MeSH-major] Enteropathogenic Escherichia coli / physiology. Growth Differentiation Factor 15 / metabolism. NF-kappa B / metabolism. Signal Transduction
  • [MeSH-minor] Animals. Cell Line. Cyclin D1 / genetics. Cyclin D1 / metabolism. Epithelial Cells / metabolism. Epithelial Cells / microbiology. Gene Expression Regulation, Bacterial. Humans. Interleukin-8 / genetics. Interleukin-8 / metabolism. Intestinal Mucosa / cytology. Intracellular Signaling Peptides and Proteins / genetics. Intracellular Signaling Peptides and Proteins / metabolism. Mice. Mice, Inbred C57BL. Phosphorylation. Transcription Factor RelA / genetics. Transcription Factor RelA / metabolism. Transforming Growth Factor beta / genetics. Transforming Growth Factor beta / metabolism

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Am Coll Surg. 2003 Dec;197(6):974-84 [14644286.001]
  • [Cites] Infect Immun. 1982 Nov;38(2):798-801 [6754624.001]
  • [Cites] Int J Colorectal Dis. 2004 Jul;19(4):334-42 [15103488.001]
  • [Cites] Infect Immun. 1984 Nov;46(2):612-4 [6389354.001]
  • [Cites] Rev Infect Dis. 1987 Jan-Feb;9(1):28-53 [3547577.001]
  • [Cites] J Clin Gastroenterol. 1992 Jun;14(4):302-8 [1607606.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11514-9 [9326641.001]
  • [Cites] Genes Dev. 1998 Aug 15;12(16):2445-62 [9716398.001]
  • [Cites] Hepatogastroenterology. 1998 Sep-Oct;45(23):1552-8 [9840104.001]
  • [Cites] J Leukoc Biol. 1999 Jan;65(1):2-5 [9886240.001]
  • [Cites] Cell Tissue Res. 1999 Jul;297(1):103-10 [10398887.001]
  • [Cites] Infect Immun. 2005 Feb;73(2):1161-70 [15664959.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2005 Mar;288(3):G422-30 [15701621.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Feb 7;103(6):1876-81 [16446436.001]
  • [Cites] Infect Immun. 2006 May;74(5):2522-36 [16622187.001]
  • [Cites] Cancer Res. 2006 May 15;66(10):4983-6 [16707416.001]
  • [Cites] Proteomics. 2006 Jul;6(13):3926-37 [16739128.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16278-83 [17050687.001]
  • [Cites] Cell Microbiol. 2007 Aug;9(8):1909-21 [17388785.001]
  • [Cites] Appl Environ Microbiol. 2007 Dec;73(23):7548-51 [17933914.001]
  • [Cites] Curr Opin Gastroenterol. 2008 Jan;24(1):32-7 [18043230.001]
  • [Cites] Inflamm Bowel Dis. 2008 Jan;14(1):114-24 [17763472.001]
  • [Cites] Infect Immun. 2008 Apr;76(4):1410-22 [18227166.001]
  • [Cites] J Infect Dis. 2008 Jul 1;198(1):143-9 [18498239.001]
  • [Cites] PLoS One. 2009;4(5):e5517 [19436735.001]
  • [Cites] Infect Immun. 2009 Oct;77(10):4406-13 [19620340.001]
  • [Cites] Nat Rev Immunol. 2009 Nov;9(11):778-88 [19855404.001]
  • [Cites] PLoS Pathog. 2009 Dec;5(12):e1000708 [20041225.001]
  • [Cites] Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):3076-80 [20133635.001]
  • [Cites] Nat Immunol. 2010 Aug;11(8):656-65 [20644571.001]
  • [Cites] Mol Microbiol. 2010 Dec;78(5):1232-45 [21091507.001]
  • [Cites] PLoS Pathog. 2010;6(12):e1001231 [21187904.001]
  • [Cites] Cell Res. 2011 Jan;21(1):146-58 [21151201.001]
  • [Cites] Scand J Immunol. 2011 Apr;73(4):268-83 [21204905.001]
  • [Cites] Curr Top Microbiol Immunol. 2011;349:145-58 [20838961.001]
  • [Cites] Inflamm Allergy Drug Targets. 2011 Jun;10(3):198-207 [21428911.001]
  • [Cites] Infect Immun. 2011 Jun;79(6):2224-33 [21402761.001]
  • [Cites] Gut Microbes. 2011 Jan-Feb;2(1):34-41 [21637016.001]
  • [Cites] Infect Immun. 2011 Sep;79(9):3552-62 [21746856.001]
  • [Cites] PLoS One. 2011;6(10):e27030 [22046438.001]
  • [Cites] PLoS Pathog. 2011 Dec;7(12):e1002414 [22144899.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):109-14 [10618379.001]
  • [Cites] J Biol Chem. 2000 Sep 15;275(37):28937-46 [10874048.001]
  • [Cites] J Infect Dis. 2001 Jul 15;184(2):227-30 [11424022.001]
  • [Cites] J Infect Dis. 2002 Dec 1;186(11):1682-6 [12447748.001]
  • [Cites] Nat Med. 2003 May;9(5):575-81 [12692538.001]
  • [Cites] Clin Cancer Res. 2003 Jul;9(7):2642-50 [12855642.001]
  • [Cites] Cancer Res. 2003 Aug 1;63(15):4648-55 [12907645.001]
  • [Cites] Cancer Res. 1977 Dec;37(12):4352-60 [922726.001]
  • [Cites] N Engl J Med. 1980 Jan 10;302(2):99-101 [6985701.001]
  • [Cites] Gastroenterology. 1982 Aug;83(2):441-54 [7044882.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2452-7 [14983030.001]
  • (PMID = 23403560.001).
  • [ISSN] 1098-5522
  • [Journal-full-title] Infection and immunity
  • [ISO-abbreviation] Infect. Immun.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Growth Differentiation Factor 15; 0 / Interleukin-8; 0 / Intracellular Signaling Peptides and Proteins; 0 / NF-kappa B; 0 / TAB3 protein, human; 0 / Transcription Factor RelA; 0 / Transforming Growth Factor beta; 136601-57-5 / Cyclin D1
  • [Other-IDs] NLM/ PMC3676000
  •  go-up   go-down


28. |......... 8%  Darkoh C, DuPont HL: Unraveling the role of host endocytic proteins in pedestal formation during enteropathogenic Escherichia coli infection. J Infect Dis; 2011 Sep 1;204(5):667-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Unraveling the role of host endocytic proteins in pedestal formation during enteropathogenic Escherichia coli infection.
  • [MeSH-major] Adaptor Protein Complex 2 / physiology. Adaptor Proteins, Vesicular Transport / physiology. Calcium-Binding Proteins / physiology. Enteropathogenic Escherichia coli / metabolism. Escherichia coli Infections / metabolism. Host-Pathogen Interactions. Intracellular Signaling Peptides and Proteins / physiology. Phosphoproteins / physiology

  • MedlinePlus Health Information. consumer health - E. Coli Infections.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentOn] J Infect Dis. 2011 Sep 1;204(5):695-703 [21810914.001]
  • (PMID = 21810916.001).
  • [ISSN] 1537-6613
  • [Journal-full-title] The Journal of infectious diseases
  • [ISO-abbreviation] J. Infect. Dis.
  • [Language] eng
  • [Publication-type] Comment; Editorial
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Adaptor Protein Complex 2; 0 / Adaptor Proteins, Signal Transducing; 0 / Adaptor Proteins, Vesicular Transport; 0 / Calcium-Binding Proteins; 0 / EPS15 protein, human; 0 / Intracellular Signaling Peptides and Proteins; 0 / Phosphoproteins; 0 / epsin
  •  go-up   go-down


top


2. Definitions


3. Related RMF webpages
1. enteropathogenic escherichia coli gastrointestinal tract infection disorder
2. verotoxigenic escherichia coli gastrointestinal tract infection disorder
3. enteropathogenic escherichia coli
4. diarrhea escherichia coli enteropathogenic
5. escherichia coli infection generalized
6. infection congenital escherichia coli
7. contact or exposure to escherichia coli e coli
8. escherichia coli meningitis disorder
9. escherichia coli
10. imaging gastrointestinal system ultrasonography gastrointestinal tract
11. escherichia coli infections
12. escherichia coli o157
13. escherichia coli proteins
14. adhesins escherichia coli
15. meningitis escherichia coli
16. diarrhea escherichia coli
17. enterohemorrhagic escherichia coli
18. escherichia coli k12
19. enterotoxigenic escherichia coli
20. escherichia coli vaccines
21. malignant neoplasm of gastrointestinal tract disorder
22. diarrhea escherichia coli enteroinvasive
23. diarrhea escherichia coli enterohemorrhagic
24. diarrhea escherichia coli enterotoxigenic
25. diarrhea escherichia coli enteroaggregative
26. shiga toxigenic escherichia coli
27. urinary tract infection in pregnancy disorder
28. gastrointestinal tract
29. acute lower respiratory tract infection disorder
30. gastrointestinal tract enterostomy
31. gastrointestinal tract hypomotility
32. gastrointestinal tract influenza
33. lower gastrointestinal tract
34. upper gastrointestinal tract
35. git gastrointestinal tract injury
36. gastrointestinal tract small intestine
37. gastrointestinal tract x ray
38. hemorrhage gastrointestinal tract newborn
39. tuberculosis gastrointestinal tract etiology
40. abnormal diagnostic imaging gastrointestinal tract
41. gastrointestinal nuclear tract of imaging medicine study
42. bacterial infection due to e coli
43. respiratory tract infection chronic lower respiratory tract
44. infection urinary tract
45. infection respiratory tract
46. infection respiratory tract chronic
47. tuberculosis infection urinary tract
48. c pregnancy urinary tract infection
49. influenza upper respiratory tract infection
50. infection respiratory tract chronic lower

top


terms of use | advertising programs | contact us
© 2014 RecentMedicalFindings


Connect with the


RMF


audience;




Post your ad here!